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STRIATED MUSCLE SPECIFIC RIBOSOMAL PROTEIN L3-LIKE: EFFECT OF 
KNOCKOUT ON CARDIAC FUNCTION AND PROTEIN TRANSLATION  
 
Ribosomes are the molecular machinery of the cell that catalyzes synthesis of 
peptides from amino acids. The eukaryotic ribosome is made up of four strands of 
ribosomal RNA (rRNA) and ~80 ribosomal proteins. While many tissues routinely 
exhibit variations of ribosomal protein stoichiometry, tissue specific ribosomal proteins 
are rare. The ribosomal protein with the highest tissue specificity of any ribosomal 
protein is found in striated muscle, ribosomal protein L3-like (RPL3L). Other than its 
tissue specificity, association with atrial fibrillation, and chromosomal location, there is 
little known about the function of RPL3L. However, its ubiquitously expressed paralog, 
RPL3, has been well documented to be essential for ribosome biogenesis, aid in peptidyl 
transfer, and increase translational fidelity.  
This thesis, therefore, seeks to address the critical gap in knowledge on the 
function of RPL3L in striated muscle and specifically, the effect of RPL3L knockout 
(KO) on cardiac function and protein translation in vivo. To that end, a RPL3L KO 
mouse was generated that, instead of striated muscle-specific RPL3L, expresses the 
ubiquitous RPL3 in striated muscles.  
The first aim of this dissertation was to test the hypothesis that RPL3L KO would 
induce cardiac arrhythmias by expression in the atria. First the expression pattern of 
RPL3 and RPL3L in the wild-type (WT) heart were established by both RT-PCR and 
Western blot. Both indicated that while the ventricle has high expression of RPL3L, 
RPL3 is found at much lower levels (~10% that of RPL3L). The atria however, had the 
opposite expression pattern with RPL3 being high and RPL3L not expressed. In order to 
determine if the RPL3L KO mice recapitulated the fibrillation phenotype seen in humans 
with Rpl3l variants, we performed echocardiography and electrocardiography on WT and 
KO mice. No changes were observed in heart rate, ejection fraction, wall thickness during 
systole or diastole, fractional shortening or stroke volume under resting conditions. When 
telemetry fitted mice were treated with the β2 adrenergic receptor agonist, isoproterenol, 
both WT and KO mice showed a significant increase in heart rate after treatment (p=0.02 
and 0.0007 respectively) but the rate of response was significantly more rapid in KO 
mice (p= < 0.0001). Due to the increase in rate of response to isoproterenol in the KO, we 
 
     
 
hypothesized that loss of expression of RPL3L in the pace-making center of the heart, the 
sinoatrial node, was responsible for the rapid increase in heart rate To that end, single-cell 
RNA sequencing data from nuclei of the sinoatrial node, and proteomic data from the 
sinoatrial node were queried. Analysis revealed that RPL3L is expressed at a very low 
level at the mRNA level in the sinoatrial node but that it is not detected at the protein 
level. These results do not support the hypothesis that loss of RPL3L in the atria causes 
atrial fibrillation, rather this evidence suggests that if RPL3L plays a role in atrial 
fibrillation, it is likely secondary to a ventricular pathology. 
The second aim of this dissertation was to test the hypothesis that RPL3L plays a 
functionally specialized role in the ribosome causing enhanced translation of a subset of 
mRNAs, thereby conferring preferential recruitment to mRNAs which are specific to 
striated muscle. Actively translating ribosomes of cardiac tissue were isolated via 
polysome fractionation and were subsequently subjected to RNA sequencing (RNA-seq). 
Analysis revealed that there were 216 mRNAs that were differentially translated (but not 
differentially transcribed). Of these mRNAs, 68 were more highly translated in WT 
(RPL3L-ribosomes) whereas 148 were more highly translated in the KO (RPL3-
conatining ribosomes). Gene ontology of differentially translated mRNAs showed highest 
enrichment for genes involved in RNA binding and splicing. These results support the 
hypothesis that there is differential translation of a subset of mRNAs  
This study demonstrates that KO of RPL3L is not lethal, and while it does cause 
changes in cardiac response to isoproterenol, its loss is not sufficient to induce atrial 
fibrillation in mice. This study also demonstrates that RPL3L expression is robust and 
highly specific to the ventricles of the heart but that its expression exhibits only minor 
alterations on the cardiac translatome. The findings here help to further our understanding 
of translation in the heart and its effects on cardiac physiology. 
 
 





















STRIATED MUSCLE SPECIFIC RIBOSOMAL PROTEIN L3-LIKE: EFFECT OF 


















John J. McCarthy 
Director of Dissertation 
 
Kenneth Campbell 
Director of Graduate Studies 
 
06/02/2020 






The following thesis, while an individual work, benefited from the insights and 
direction of several people. First, my Thesis Chair, John J. McCarthy who was a constant 
source of encouragement, who challenged me and helped me develop into a scientist. I 
would also like to thank my committee, Charlotte Peterson, Seven Estus, Timothy 
Butterfield, Brian Delisle, and my outside examiner, Douglas Harrison. 
I would also like to thank those who helped mold me into a scientist on a daily basis 
– my lab mates: Yuan Wen, Ivan Vechetti, Alexander Alimov, Taylor Valentino, Vandre 
Casagrande-Figueiredo and Brooks Mobely. I would also like to thank Ivan Vechetti Jr. for 
his patience with me, his unending willingness to help, hear my ideas, and give feedback. I 
would like to thank Yuan Wen for always listening to my constantly new hypotheses, 
challenging my thinking, and his constant, encouraging support. I could not have done it 
without you two. I would also like to thank Shelby Meier for years of emotional and 
scientific support, as well as help preparing for my defense.  
I never intended my educational journey to go this far, nor did I think I was even 
capable of it, but I would like to thank all the people who always believed in me. Firstly, 
my family, my parents Celeste and David Peterson, my parents in law, Jane and Ron 
Brown, and all my siblings, especially my brother Joshua Peterson who was always 
unabashedly proud of me from start to finish. I would like to thank my husband, 
Christopher Brown who has supported me in every way possible and has always believed 
in me even when I did not believe in myself. When challenges arose, he was always the 




shoulder that I cried on. I cannot thank him enough for putting up with me, helping me, 
and encouraging me through this journey.  
Lastly, I would like to thank United States taxpayers. Without their support this 
research would have never been possible. I was supported both by a National Institute of 
Health grant as well as a National Science Foundation Graduate Research Fellowship. 
The NIH grant kick-started this whole project, and the NSF grant gave me the liberty to 
study what I felt were the most important things to know about the beguiling protein, 
RPL3L. Thank you to each and every taxpayer. Your support of basic research does not 






TABLE OF CONTENTS 
 
ACKNOWLEDGMENTS ........................................................................................................................... iii 
LIST OF TABLES .................................................................................................................................... viii 
LIST OF FIGURES .....................................................................................................................................ix 
CHAPTER 1. Introduction ........................................................................................................................... 1 
1.1 The History of the Ribosome ............................................................................................................. 1 
1.2 Ribosome Biogenesis ......................................................................................................................... 4 
1.3 Ribosome Function ........................................................................................................................... 7 
1.4 5' Untranslated Region ..................................................................................................................... 8 
1.4.1 Internal Ribosomal Entry Site ................................................................................................. 8 
1.4.2 Upstream Open Reading Frame ............................................................................................ 10 
1.4.3 Terminal Oligopyrimidine Tract ........................................................................................... 11 
1.5 Ribosomal Protein Stoichiometry and Paralog Substitution ........................................................... 12 
1.5.1 Ribosome Stoichiometry ....................................................................................................... 12 
1.5.2 Ribosomal Paralogs ............................................................................................................... 13 
1.5.3 Striated Muscle Specific RPL3-like ...................................................................................... 16 
1.5.4 Transcriptional Regulation .................................................................................................... 17 
1.5.5 C-terminus of RPL3L ............................................................................................................ 18 
1.5.6 Ribosome Localization .......................................................................................................... 18 
1.6 Knowledge Gap ............................................................................................................................... 20 
CHAPTER 2. Loss of cardiac specific ribosomal protein L3-like has modest effects on the cardiac 
translatome 21 
2.1 Introduction ..................................................................................................................................... 21 
2.2 Methods ........................................................................................................................................... 23 
2.2.1 Animals ................................................................................................................................. 23 
2.2.2 RNA Isolation ........................................................................................................................ 24 
2.2.3 RT-PCR ................................................................................................................................. 24 
2.2.4 Western Blot .......................................................................................................................... 25 
2.2.5 Polysome Fractionation ......................................................................................................... 26 
2.2.6 RNA-sequencing and Bioinformatics .................................................................................... 26 
2.2.7 Cardiomyocyte dispersal ....................................................................................................... 27 
2.2.8 Transverse Tubules ................................................................................................................ 29 
2.2.9 Calcium Tolerance ................................................................................................................. 29 
2.2.10 Gene Ontology .................................................................................................................. 29 
2.2.11 Statistics ............................................................................................................................ 30 
2.3 Results ............................................................................................................................................. 30 
2.3.1 RPL3 and RPL3L Expression During Post-natal Development ............................................ 30 




2.3.3 Translational Enrichment ...................................................................................................... 33 
2.3.4 Differential Splicing .............................................................................................................. 38 
2.3.5 Calcium Handling .................................................................................................................. 40 
2.3.6 Transverse Tubules ................................................................................................................ 42 
2.4 Discussion ....................................................................................................................................... 43 
2.4.1 Summary of Findings ............................................................................................................ 43 
2.4.2 Ribosome Specialization ....................................................................................................... 43 
2.4.3 Translational Enrichment ...................................................................................................... 44 
2.4.4 Calcium Homeostasis ............................................................................................................ 44 
2.4.5 Possible Roles of RPL3L and Future Directions ................................................................... 45 
CHAPTER 3. Loss of ventricular- specific ribosomal protein rpl3l enhances response to acute 
adrenergic stimulation ................................................................................................................................ 47 
3.1 Introduction ..................................................................................................................................... 47 
3.1.1 Atrial Fibrillation ................................................................................................................... 47 
3.1.2 RPL3L Tissue Specificity ...................................................................................................... 47 
3.1.3 Knowledge Gap ..................................................................................................................... 48 
3.2 Materials and Methods ................................................................................................................... 49 
3.2.1 Animals ................................................................................................................................. 49 
3.2.2 RNA Isolation ........................................................................................................................ 49 
3.2.3 RT-PCR Analysis .................................................................................................................. 50 
3.2.4 Western Blot Analysis ........................................................................................................... 50 
3.2.5 Single-cell RNA-Sequencing Analysis .................................................................................. 51 
3.2.6 Quantitative Proteomics ........................................................................................................ 52 
3.2.7 Echocardiography .................................................................................................................. 53 
3.2.8 Electrocardiography .............................................................................................................. 53 
3.2.9 Statistics................................................................................................................................. 54 
3.3 Results ............................................................................................................................................. 55 
3.3.1 Atria and Ventricular Expression of RPL3L ......................................................................... 55 
3.3.2 Echocardiography and Electrocardiography .......................................................................... 56 
3.3.3 Single Cell RNA Sequencing of the SAN ............................................................................. 60 
3.3.4 Quantitative Proteomics ........................................................................................................ 61 
3.4 Discussion ....................................................................................................................................... 63 
3.4.1 Summary of Findings ............................................................................................................ 63 
3.4.2 Tissue Specificity .................................................................................................................. 63 
3.4.3 Possible Roles of RPL3L ....................................................................................................... 64 
3.4.4 Phenotype of RPL3L KO Mice ............................................................................................. 65 
3.4.5 Possible Roles of RPL3L in Atrial Fibrillation ..................................................................... 66 
3.4.6 Genome Wide Association Studies ....................................................................................... 68 
CHAPTER 4. Reflections and looking ahead to future studies ............................................................... 69 
4.1 Reflections ....................................................................................................................................... 69 
4.1.1 The Translatome .................................................................................................................... 70 
4.1.2 Calcium Handling and Cardiac Function .............................................................................. 71 
4.1.3 Atrial Fibrillation ................................................................................................................... 72 
4.2 Future Directions ............................................................................................................................ 73 
4.2.1 Ribo-seq................................................................................................................................. 73 




4.2.1.2 Elongation .................................................................................................................... 74 
4.2.1.3 Processivity .................................................................................................................. 74 
4.2.2 Muscle Function .................................................................................................................... 75 
4.2.3 Sinoatrial Node Subpopulations ............................................................................................ 75 
APPENDICES ............................................................................................................................................. 77 







LIST OF TABLES 







LIST OF FIGURES 
Figure 1: Up-regulation of Rpl3l in the heart during post-natal development. ................. 31 
Figure 2: Effective knockdown of RPL3 expression in the heart. .................................... 33 
Figure 3 Modest differences in heart polysome composition between RPL3L KO and 
WT. ................................................................................................................................... 35 
Figure 4: Transcript abundance is primary determinant of translation. ............................ 37 
Figure 5: Gene ontology of differentially spliced mRNAs. .............................................. 39 
Figure 6: KO cardiomyocytes show an increase in calcium sensitivity. .......................... 41 
Figure 7: T-tubules of RPL3L mice show a decrease in regularity. ................................. 42 
Figure 8. Ventricular specific expression of RPL3L. ....................................................... 56 
Figure 9: Loss of RPL3L does not affect cardiac function. .............................................. 58 
Figure 10: Electrical activity of the heart in WT and KO mice. ....................................... 59 
Figure 11: Low expression of Rpl3l in sinoatrial node..................................................... 61 




CHAPTER 1. INTRODUCTION 
 
1.1 The History of the Ribosome 
 The theory that a virus could cause cancer was a hotly debated topic in the 1920’s. 
Despite the rudimentary knowledge of viruses, the theory that a virus could cause cancer 
was ridiculed (Rheinberger 1995). The nay-sayers reasoned that because cancer arose 
randomly in the body it must be an endogenous chemical mutagen. A young medical 
doctor and scientist, who wished to make his mark by disproving the theory that a virus 
could cause cancer, boarded a ship in Belgium and sailed to New York to work with 
James B. Murphy at Rockefeller Institute in 1929 (Rheinberger 1995). Six years later 
while searching for the amorphous chemical that he hypothesized was causing a 
particular tumor in chicken, the young doctor, Albert Claude, found a small but active 
tumor producing fraction that was unexpected. He described a “particulate matter of 
uniform size” in the microsome fraction which he believed to be in some way associated 
with mitochondria and play a role in cell differentiation (Claude 1940). After much 
analysis he noted that these particles were made up of “nucleoprotein of the ribose type,” 
and lipid, and when centrifuged it separated in a stepwise fashion. This was the newest 
suspect for causing cancer and Claude threw himself into this research for the next 
decade. But much to Claude’s dismay, when using a non-cancerous chick embryo as a 
negative control, he also found large quantities of these particles. Claude was rightfully 
dismayed, his theory that this active fraction was causing cancer appeared to be fatally 
flawed because it was also in non-cancerous cells. He concluded that these particles must 




(Claude 1940).  Not dissuaded, Claude continued studying the ribonucleoprotein particles 
of the microsomal fraction and had many theories about their function - a favorite of 
which was that they were immature mitochondria. Despite his efforts, little headway was 
made in discerning the role of these mysterious particles.  
Meanwhile, George Palade, a Romanian scientist was attempting to map the 
enzymatic landscape of the cell. Frustrated with salt gradients causing mitochondrial 
rupture, he employed sucrose centrifugation and found that this produced a robust 
microsome fraction. Coincidentally Palade combined both biochemistry and electron 
microscopy to image cellular fractions and noted that there was a “small, granular 
component” of the cell that was found on much of the endoplasmic reticulum but their 
connection to the ribonucleolar microsomes remained elusive (Palade 1955). Over the 
next decade research on these particles found in the microsomal fraction expanded 
(Rheinberger 1995). While their role in the cell was hotly debated, everyone agreed that 
the name “ribonucleoprotein particles of the microsome fraction” was too long. When 
R.B. Roberts suggested the abbreviation “ribosome” the rest of the community embraced 
the name (Roberts 1958). Thus, the beginning of ribosome research was born. 
In 1955, John Littlefield demonstrated that the ribosome was responsible for amino 
acid incorporation (Littlefield, Keller et al. 1955). By adding radiolabeled amino acids 
into the ribosomal fraction, Dr. Littlefield showed that although proteins were being 
labeled, the ribosome itself was rarely labeled - indicating that the ribosome was involved 
in translation but not being highly translated itself (Littlefield, Keller et al. 1955). 
Scientists hypothesized that the RNA in a ribosome was for informational use and that 




Some even went as far as proposing a one gene, one ribosome, one protein hypothesis 
(Brenner, Jacob et al. 1961). However this was hotly debated because if this were true, 
there should be ribosomes of varying sizes due to variation in gene length; but because 
ribosomal weight was highly consistent between tissues and between many organisms, all 
the RNA within a ribosome had to be made of the same or similar RNA. In the spring of 
1961, Sydney Brenner and colleagues published an article called "An unstable 
intermediate carrying information from genes to ribosomes for protein synthesis" that 
outlined what is now known as messenger RNA (Brenner, Jacob et al. 1961). Within a 
matter of a few years, the remaining mysteries of transfer RNA (tRNA), ribosomal RNA 
(rRNA), ribosomal proteins and the fundamental enzymatic reactions they collectively 
underwent, were elucidated and research shifted from functional analysis of the ribosome 
to structural inquiries of the ribosome and the specifics of ribosome biogenesis.  
Initially naming of ribosomal proteins did not follow any structured conventions, 
and each lab would often have their own naming conventions which lead to publications 
between labs to be confusing and almost impossible to use due to lack of consistent 
identifiers for any given protein (Wittmann, Stofflet et al. 1971). In 1971, a naming 
convention was implemented that solved many of these issues. The proposed ribosomal 
protein nomenclature dictated that the ribosomal proteins be first named denoting their 
association with the ribosome (ribosomal protein, RP) and then their association with 
either the large or small subunit (L or S respectively), followed by a number. A variation 
of this naming convention is used to denote paralogs. Paralogs are given the same name 
as the protein from which they arose but with a suffix of Like (L) or denoted with a letter 




2016). Additionally, ribosomal proteins that are found on sex chromosomes contain X or 
Y to indicate the chromosome (Lopes, Miguel et al. 2010). Although new naming 
conventions have been proposed, this model is the most commonly used and will be used 
for the remainder of this dissertation (Ban, Beckmann et al. 2014).  
1.2  Ribosome Biogenesis 
Ribosome biogenesis requires a symphony of RNA polymerases I, II, and III, as 
well as assembly factors, chaperones, and protein synthesis of ribosomal proteins.  
Transcription of ribosomal DNA (rDNA) requires selectivity factor 1 complex (SL-
1, also known as TIF-1B), upstream binding factor (UBF), RNA Polymerase transcription 
factor 3 (TIF-1A, also known as Rrn3), and all 14 subunits of RNA polymerase I (Pol I) 
which together are known as the preinitiation complex (PIC) (Buttgereit, Pflugfelder et 
al. 1985, Kuhn and Grummt 1992, Yamamoto, Nogi et al. 1996, Voit, Hoffmann et al. 
1999, Friedrich, Panov et al. 2005, Fernandez-Tornero, Moreno-Morcillo et al. 2013). 
UBF binds as a homodimer to both the core promoter and the upstream core element to 
create a DNA loop structure (O'Mahony, Smith et al. 1992, Reeder 1995). The SL-1 
complex is recruited to the promoter where it then binds both UBF and the rDNA. The 
Pol I/TIF-1A complex is then recruited to the promoter to complete the PIC (Bell, 
Learned et al. 1988). rDNA transcription continues until Pol I encounters transcription 
termination factor 1. Termination proteins stall transcription and transcript release factors 
dissociate Pol I from the rDNA (Mason, Sander et al. 1997, Jansa and Grummt 1999, 
Sirri, Roussel et al. 1999).  Transcription by Pol I produces a single 47S RNA that 
contains the mature 18S, 5.8S, and 28S rRNA with two internal transcribed spacers and 




processed by post-transcriptional cleavage into 28S, 5.8S and 18S  rRNA (Lazdins, 
Delannoy et al. 1997). As the ribosome is maturing there are ~150 non-ribosomal 
proteins that associate to aid in biogenesis (Tschochner and Hurt 2003).  
In contrast, 5S rRNA transcription is relatively simple with pol III transcribing 5S 
RNA, which then binds to RPL5. The 5S-RPL5 complex is then shuttled to the nucleolus 
and begins aiding in ribosome biogenesis of the large subunit (Michael and Dreyfuss 
1996, Dechampesme, Koroleva et al. 1999). 
Transcription of mRNAs required for ribosome assembly occurs by RNA 
polymerase II. This process happens rapidly and then the mRNAs are shuttled to the 
cytoplasm for translation. After translation, the proteins are shuttled to the nucleolus, via 
a nucleolar localization signal, for ribosome biogenesis (Moreland, Nam et al. 1985, 
Rosorius, Fries et al. 2000, Meyer, Hung et al. 2007). In the nucleolus the ribosomal 
proteins and rRNA are sequentially incorporated into the ribosome in the final stages of 
subunit biogenesis (Kruiswijk, Planta et al. 1978, Mitterer, Murat et al. 2016). Once the 
large and small subunits are fully formed, they are exported to the cytosol where they can 
then assemble on mRNA and begin translation. 
Given that ribosome biogenesis is the most expensive metabolic process for cells, 
ribosome biogenesis is tightly regulated (Warner 1999, Raska, Koberna et al. 2004). 
Production of rRNA is negatively regulated by p53 (a tumor suppressor) and positively 
regulated by c-Myc (an oncogene). When c-Myc is activated by a growth stimulus it 
directly binds to consensus elements in rDNA and associates with the Pol I-specific SL1 
which then causes transcription of rRNA(Grandori, Gomez-Roman et al. 2005). 




will bind to Mdm2 which then activates p53, halting transcription of rDNA and 
consequently, ribosome biogenesis as a whole  (Golomb, Volarevic et al. 2014). During 
times of cellular stress or differentiation, ribosome biogenesis is reduced via chromatin 
remodeling and inhibition of transcription  (Leary and Huang 2001). These mechanisms 
together ensure that ribosome biogenesis occurs only when needed and that this costly 
cellular function ceases as soon as the cell’s requirements are met. 
While there are numerous proteins that target many areas of ribosome biogenesis, 
there is one master regulator: mammalian target of rapamycin (mTOR).  mTOR is a 
serine/threonine protein kinase that when activated can modulate cell growth and protein 
synthesis through phosphorylation of targets including ribosomal protein S6 kinase 
(RPS6K) and 4E binding proteins (4EBP). After activation, RPS6Ks can then increase 
protein synthesis by enhancing RNA helicase activity to promote initiation, elongation 
factors to increase the speed of translation, and increase ribosome biogenesis (Wang, Li 
et al. 2001, Shahbazian, Roux et al. 2006, Jastrzebski, Hannan et al. 2007). During 
periods of cellular stress, 4EBPs interact with eIF4E, which inhibits formation of the 
initiation complex. When 4EBPs are phosphorylated by effectors of mTOR, eIF4E is 
released from 4EBPs and can bind to eIF4G to form the initiation complex (Beretta, 
Gingras et al. 1996).  mTOR regulation and effects are far reaching and complex, but 
here we briefly discuss a few of its effects on translation; for a more comprehensive 
review of mTOR see Gringas et al and Drummond et al (Gingras, Kennedy et al. 1998, 




1.3  Ribosome Function 
The function of the ribosome is to catalyze the synthesis of single amino acids into 
peptides. Ribosomal proteins stabilize the rRNA while it catalyzes the transfer of an 
amino acid from the charged tRNA, to a chain of amino acids. Although simple 
sounding, translation is a multi-step process that requires a host of protein factors and is 
energetically expensive.  
There are three classical stages to translation: Initiation, Elongation and 
Termination. Initiation of translation in eukaryotic cells begins with the 40S (small) 
subunit, in complex with eukaryotic initiation factor 3 (eIF3) and eIF2-GTP/Met-tRNA, 
are recruited to the 5' cap of an mRNA (Merrick 1992, Hinnebusch 2006). The half-mer 
and its complex scan the mRNA from 5' to 3' until a start codon is encountered. Once the 
start codon (usually AUG) is positioned in the P-site of the 40S ribosome, eIF5 stimulates 
GTP hydrolysis which causes eIF2 to dissociate from the small subunit, eIF5B then 
associates allowing the 60S (large) subunit to join the 40S subunit and complete 80S 
ribosome assembly (Pestova, Lomakin et al. 2000). Elongation begins when eukaryotic 
elongation factor (eEF) 1A binds GTP and an aminoacylated tRNA at the A-site of the 
ribosome. tRNA codon recognition triggers GTP hydrolysis of eEF1A causing it to 
release from the ribosome which allows the tRNA to move into the A-site (Sasikumar, 
Perez et al. 2012). eEF1B will then catalyze eEF1A bound ADP back to ATP so that it is 
once again active. After peptide bond formation has occurred, eEF2 translocates the 
mRNA by one codon so that the next codon is in the A-site (Riis, Rattan et al. 1990). 
Translation termination begins when the ribosome encounters a stop codon (UAA, UGA 
or UAG) in the A-site. Eukaryotic release factor (eRF) 1 and 3 act in a collaborative 




codon (Alkalaeva, Pisarev et al. 2006) eRF1 has been shown to have a high level of 
accuracy in codon discrimination, likely an evolutionary adaptation that prevents 
incorrect elongation termination (Salas-Marco and Bedwell 2005). Once termination has 
begun eRF3 increases the speed of termination by acting as a termination specific 
GTPase (Salas-Marco and Bedwell 2004).  
1.4 5' Untranslated Region 
Regulation of translation is typically carried out via the 5' untranslated region (5'-
UTR) of mRNA. The 5'-UTR region can encode motifs that either recruit ribosomes, 
repress translation or both depending on cellular stimuli. Three of the more common 
motifs are internal ribosomal entry sites (IRES), upstream open reading frames (uORF), 
and 5' terminal oligopyrimidine tracts (5'TOP).  
 
 
1.4.1 Internal Ribosomal Entry Site 
While most translation initiation occurs on the 5' cap of mRNA, an IRES occurs 
within the 5'-UTR of mRNAs and preferentially recruits the ribosome for translation. 
This mechanism is commonly used by viruses to hijack the translational machinery of the 
cell so that viral mRNAs are preferentially translated over host mRNAs (Quade, 
Boehringer et al. 2015). Some viral IRESs can even begin translation in the absence of 
initiation factors, an ability that is further exploited by expression of a protease that 
cleaves eIF4G, a cap binding adaptor protein (Belsham, McInerney et al. 2000, Pestova 




ribosomes from host mRNA, blocks further initiation via the 5' cap, and increases IRES 
mediated translation.  
In eukaryotes, IRESs are used to enhance translation of required mRNAs even 
during times of translational suppression, but they can also recruit specific ribosomal 
proteins and perhaps act in a more specialized capacity.  
In mammalian systems IRESs are commonly used to translate mRNAs that are 
specific to differentiated cells. For instance, in the neuronal system, dendrites require 
constant protein production to ensure lasting changes after synaptic activation, but the 
initiation machinery is found at relatively low concentrations. Pinkstaff et al 
demonstrated that there were key mRNAs that were translated independent of 5' cap after 
synaptic activation (Pinkstaff, Chappell et al. 2001). Upon investigation, they found the 
alpha subunit of calcium-calmodulin-dependent kinase II (CAMK2A), activity-regulated 
cytoskeletal associated protein (ARC), dendrin (DDN), microtubule associated protein 2 
(MAP2) and neurogranin (NRGN) were all translated via IRESs. These types of mRNAs 
that are enriched in specific tissues are believed to have evolved IRESs so that even when 
global protein translation is decreased, key mRNAs can still be translated.  
IRESs have also been reported to be involved in the preferential recruitment of 
ribosomes with specific ribosomal protein composition. Xue et al demonstrated that 
ribosomes containing RPL38 preferentially associated with the 5'UTR of HOX mRNAs 
(Xue, Tian et al. 2015). When RPL38 was mutated, there was no longer preferential 
translation which lead to abnormalities in eye, tail and skeletal development in mice 




Shi et al showed the association of different ribosomal proteins with the ribosome 
influenced the composition of the polysomes such RPS25-containing ribosomes were 
significantly more likely to translate mRNAs involved in organelle organization whereas 
RPL10A-containing ribosomes were more likely to translate mRNAs involved in 
embryonic development (Shi, Fujii et al. 2017).They confirmed that many of these 
mRNAs contained IRESs, while other mRNAs conferred 5'-UTR ribosome recruitment 
via an unknown mechanism. 
 
 
1.4.2 Upstream Open Reading Frame 
Upstream open reading frames (uORFs) are translational start sites that are in the 
5'-UTR. This sequence causes ribosomes to prematurely initiate, begin translation, and 
then terminate due to an in-frame stop codon before the true start site at the beginning of 
exon 1. By allowing ribosomes to initiate and terminate before translation of the encoded 
protein, this 5' element can suppress protein expression.  
uORFs can also decrease translation of mRNAs by increasing mRNA degradation 
(Matsui, Yachie et al. 2007). Non-sense mediated decay is a process that normally detects 
and degrades mRNAs that code for non-functional proteins or proteins that have harmful 
mutations. Non-sense mutations that lead to a premature stop codon, are preferentially 
degraded to ensure incorrectly made proteins do not remain in the cell. uORFs in mRNA 
can mimic aberrant stop codons to promote their own degradation (Oliveira and 
McCarthy 1995, Tanaka, Sotta et al. 2016). Additionally, some uORFs produce cis-acting 




therefore targeting the mRNA for degradation (Meijer and Thomas 2003, Oyama, Itagaki 
et al. 2004, Gaba, Jacobson et al. 2005).  
 
Considering about half of all human and mouse genes contain uORFs in their 
UTRs it is remarkable that any of these transcripts are translated. However, the context in 
which an uORF appears can alter its ability to be translated. For instance, some uORF 
AUGs have “high visibility” (an A at the -3 position relative to the AUG) leading to 
almost exclusive translation of the uORF (Baim and Sherman 1988). On the other hand, 
if the 5'-UTR length leading up to the uORF is below 15 nucleotides, the uORF will 
likely not be translated, and the ribosome will have a much higher chance of beginning 
translation at the true start site (van den Heuvel, Bergkamp et al. 1989). Two factors can 
help determine ribosome re-initiation, the length of the uORF, and the context of the stop 
codon. Shorter uORFs allow for more efficient reinitiation likely due initiation factors 
still being in close proximity if elongation is quite short (Luukkonen, Tan et al. 1995, 
Hinnebusch 2006). If the uORF is longer than 35 codons, it is very unusual to have re-
initiation (Luukkonen, Tan et al. 1995).  
1.4.3 Terminal Oligopyrimidine Tract 
Given the energetically costly nature of ribosome biogenesis, and protein 
translation, it seems intuitive that there would be a consensus sequence to up-regulate or 
suppress production of translational machinery in varying growth or starvation 
conditions. Five prime terminal oligopyrimidine tract (5'-TOP) motifs are just such a 
sequence. TOP-containing mRNAs encode proteins of the translational machinery and 




cysteine residue at the cap site of a 5'-UTR, followed by 4-15 pyrimidines (Mariottini, 
Bagni et al. 1988, Nakanishi, Kohno et al. 1988, Perry and Meyuhas 1990, Levy, Avni et 
al. 1991, Jefferies, Reinhard et al. 1994, Perry 2005). During times of growth, mTORC-1 
phosphorylates the translational repressor 4E-BP1 causing it to dissociate from eIF4E; 
the freed eIF4E can then bind capped mRNAs and begin translation initiation. During 
cellular stress suppression, mTORC-1 inactivation causes 4E-BP to remain in the 
unphosphorylated state, bound to EIF4E which diminishes its ability to bind TOP motifs 
more than other mRNAs (Avni, Biberman et al. 1997, Hornstein, Git et al. 1999, 
Thoreen, Chantranupong et al. 2012, Miloslavski, Cohen et al. 2014). 
 
1.5 Ribosomal Protein Stoichiometry and Paralog Substitution 
1.5.1 Ribosome Stoichiometry 
Eukaryotic ribosomes contain 79 ribosomal proteins, many of which are essential 
for biogenesis and function (Martin-Marcos, Hinnebusch et al. 2007, Rosado, Kressler et 
al. 2007, Russ 2007, Poll, Braun et al. 2009, Al-Hadid, Roy et al. 2016). Even 
haploinsufficiency of some ribosomal proteins can cause detrimental phenotypic changes 
or even death. For example, when a single copy of RPS6 was knocked out in the mouse  
it was embryonic lethal (Panic, Tamarut et al. 2006). Patients that are haploinsufficient 
for the ribosomal protein SA are born without spleens and are prone to life threatening 
infections (Bolze, Mahlaoui et al. 2013). However, not all ribosomal proteins are 
required, and in many cases the ribosome’s requirements vary by organism, and tissue 




ribosome were observed from tissue to tissue, many believed this to be due to the 
challenges of ribosome isolation rather than actual, biologically relevant changes in 
ribosome composition. The notion of ribosome homogeneity was perpetuated by the fact 
that most research on the ribosome was, and still is, done in bacteria and yeast. While 
there are some changes in both bacterial and yeast ribosome composition under certain 
conditions, most laboratories studying ribosome heterogeneity are focused on changes in 
mammalian systems (Huang, Zhao et al. 2006, Shi, Fujii et al. 2017, Parks, Kurylo et al. 
2018). Over the past few decades there has been ample evidence that ribosome protein 
composition is a fluid ebb and flow between various ribosomal proteins rather than static 
expression of 79 identical ribosomal proteins (Slavov, Semrau et al. 2015, Chaillou, 
Zhang et al. 2016, Guimaraes and Zavolan 2016). The first evidence of differential 
ribosome stoichiometry in a developing embryo was in the heart. Kirby et al 
demonstrated that RPL10 was increased in neural crest cells during septation of the 
outflow tract in the developing heart (Kirby, Cheng et al. 1995). 
1.5.2 Ribosomal Paralogs 
Seventy-nine ribosomal proteins and 4 strands of rRNA allows for many 
variations of ribosome composition but the introduction of paralogs further increase the 
possibilities (Kirby, Cheng et al. 1995, Ban, Nissen et al. 2000, Sugihara, Honda et al. 
2010, Parks, Kurylo et al. 2018). A duplication event millions of years ago in eukaryotes 
lead to multiple copies of ribosomal genes; it is hypothesized that this duplication event 
increased fitness due to lower chances of disease caused by haploinsufficiency. Over the 
years, these duplicated ribosomal genes have accumulated mutations and given rise to 




Wong, Li et al. 2014, Guimaraes and Zavolan 2016). Arabidopsis is believed to have 
gone through three duplication events leading to 80 ribosomal genes that are encoded by 
249 genes (Lynch and Conery 2000, Simillion, Vandepoele et al. 2002). For years 
paralogs of ribosomal genes were believed to be functionally redundant until Rotenberg 
et al showed that the knockdown of RPL16 paralog caused phenotypic defects in 
Saccharomyces cerevisiae, indicating the paralog was functional (Rotenberg, Moritz et 
al. 1988). Since then, the functional significance of paralogs has come to the forefront of 
ribosomal studies and several of these duplicated genes have been shown to serve in a 
specialized capacity. In Arabidopsis RPL16A is specific to root stele and anthers and is 
thought to be important in pollen production; its paralog, RPL16B, is not tissue specific 
but is considered to be necessary for cell division in Arabidopsis (Williams and Sussex 
1995). 
Although the core RPL3 is a single gene in yeast, there are two variations in 
plants that are highly conserved (Fried and Warner 1981, Kim, Zhang et al. 1990, Nishi, 
Kidou et al. 1993, Barakat, Szick-Miranda et al. 2001). In rice, RPL3A and RPL3B only 
differ in 5 amino acids, 4 of which are very minor alterations (chemically similar amino 
acids). However, these small changes have led to functional diversity. Zheng et al. 
demonstrated that in rice RPL3A cannot compensate for the loss of RPL3B (Zheng, 
Wang et al. 2016). A mutation of RPL3B caused plants to be smaller, have retarded root 
growth, as well as vascular, and leaf defects; yet a mutation of RPL3A had no effect. 
Similar results were found when the same gene was knocked out in N. tabacum (Popescu 




protein paralog are signs that particular ribosomal proteins may cause the ribosome to 
function in a specialized capacity. 
Some ribosomal protein genes are found in sex chromosomes making a 
compelling argument that specific ribosomal proteins could play an important role in 
reproductive functions. For example, RPS4Y2 is expressed only in testes and prostate 
while its paralog, RPS4Y1, is expressed throughout the body, indicating that that 
RPS4Y2 carries out a function that is not met by the ubiquitous RPL4Y1. Men who 
underwent normal spermatogenesis showed 5 times more RPS4Y2 than men who were 
azoospermic. Although the sequences of these two homologs is 94% conserved, their C- 
termini are very different, which is believed to cause interactions with testes and prostate 
specific extra-ribosomal factors (Lopes, Miguel et al. 2010). 
Kondrashov et al. demonstrated that there is differential translation of a subset of 
HOX genes when RPL38 is mutated, but not when RPS19, RPS20, RPL24, or RPL29 are 
mutated; indicating that not all ribosomal proteins confer a specialized function to the 
ribosome (Kondrashov, Pusic et al. 2011). After a similar study, Komili proposed a 
“ribosomal code” by which the variation of ribosome composition alters the type and 
frequency of transcripts that are translated providing for a level of gene regulation that 
has been, until recently, unrecognized (Komili, Farny et al. 2007). Not only do ribosomal 
proteins vary between tissue types but ribosome composition may affect whether or not 
the transcript accumulates in polysomes or remains a monosome (Slavov, Semrau et al. 
2015). Ribosomes from mouse embryonic stem cells that were in the polysome fraction 
showed supra-stoichiometric quantities of RPL30, RPL27A, RPS18, and RPS17, while 




et al. 2015). These findings provide evidence that ribosomal composition may alter the 
frequency of translation of some mRNAs.  
 
1.5.3 Striated Muscle Specific RPL3-like 
RPL3 is a ubiquitously expressed protein that is essential for ribosome assembly, 
interacts with three other ribosomal proteins, and touches the peptidyl transferase site 
within the ribosome (Ban, Nissen et al. 2000, Smith, Lee et al. 2008, Garcia-Gomez, 
Fernandez-Pevida et al. 2014). Interestingly, its paralog, RPL3L, is only expressed in 
striated muscle (Van Raay, Connors et al. 1996).  
The expression of these ribosomal protein paralogs also shows a high degree of 
variation throughout the lifecycle. RPL3 expression during mouse post-natal 
development is highest at day one and then progressively decrease until day 21 where its 
expression remains low under resting conditions.  The expression of its paralog, RPL3L, 
is the inverse of RPL3 (Chaillou, Zhang et al. 2016). Under normal conditions in mice 
during adulthood, RPL3 levels are low and its paralog, RPL3L, is relatively high (Komili, 
Farny et al. 2007). However, during skeletal muscle hypertrophy RPL3 is upregulated by 
5-fold and RPL3L expression decreased by 82% (Chaillou, Zhang et al. 2016). Such 
differential expression of RPL3L and its paralog during hypertrophy suggests there are 
different classes of ribosomes in skeletal muscle under resting conditions and during 
growth.  
The benefit of ribosomal transcript specificity in skeletal muscle is obvious - 




daily conditions, and a paralog that has an increased affinity for muscle sarcomeric 
transcripts would be a highly energy efficient mechanism to regulate a metabolically 
costly function - skeletal muscle growth. 
 
1.5.4 Transcriptional Regulation 
Commonly ribosomal protein regulation is seen as operating as one concerted 
regulatory pathway that responds to stimuli. However, differential expression of paralogs 
indicates that there is another level of complexity; there must be some secondary 
mechanism of modulating ribosomal protein expression that is dependent upon a 
particular stimulus. There has been almost no research on the regulation of ribosomal 
paralogs at the transcriptional level. The regulatory mechanism of RPL3L is completely 
unknown but some evidence suggests that ribosomal proteins may repress expression of 
their paralog. O’Leary et al reported that, in yeast, expression of RPL22 decreased the 
stability of its own paralog, RPL22-like1, by binding to a hairpin loop on the mRNA that 
encodes for RPL22-like1 (O'Leary, Schreiber et al. 2013). Alternatively, in human cells, 
RPS16 binds to the first intron of its mRNA to inhibit its own splicing (Ivanov, 
Parakhnevich et al. 2010). In yeast, RPS28b has been shown to uncap its own mRNA 
which prevents further translation, enhancing transcript degradation (Badis, Saveanu et 
al. 2004). Although it remains to be determined, one of these regulatory mechanisms 





1.5.5 C-terminus of RPL3L 
RPL3 and RPL3L are 74% identical in amino acid sequence indicating that some 
structural similarities are necessary to function. However, their inverse expression 
patterns, and tissue specificity of RPL3L, suggest that they are not functionally 
redundant. Aside from the few amino acid alterations in the body of the protein, RPL3L 
has 8 additional amino acids on the C-terminus, which could be the key to its functional 
differences. One possible mechanism by which RPL3L-contaning the ribosome becomes 
specialized is by the C-terminus of RPL3L interacting with skeletal muscle specific 
transcripts to regulate their expression. Lopes et al hypothesized that C-terminal 
differences in ribosomal proteins might cause changes in the small and large subunit 
assembly, or alter the association of other proteins with the ribosome (Lopes, Miguel et 
al. 2010). Gamalinda and Woolford showed that C-terminal differences in ribosomal 
proteins could be the key to their function and that even minor variations of these C-
termini could completely change their chemical associations with rRNA or other 
ribosomal proteins (Gamalinda and Woolford 2014). In yeast, a loss of the external 
globular tail of RPL4 significantly compromised ribosome function, stalling ribosome 
biogenesis at 27S and subsequently reducing the amount of ribosomes found in polysome 
fractions (Gamalinda and Woolford 2014).  
 
1.5.6 Ribosome Localization 
In most organs, mature ribosomes are found either free in the cytosol, or bound to 




soluble proteins (Palade 1955). In the event that the protein being translated is non-polar, 
a lipid localization signal is translated, the ribosome halts, and the ribosome translocates 
to the endoplasmic reticulum to complete translation (Fried and Warner 1981, Walter and 
Blobel 1981, Noriega, Chen et al. 2014). Interestingly, ribosomes in striated muscle have 
yet another location where they can be bound, Z-disk (Lewis, Moskovitz et al. 2018). A 
primary function of the Z-disk is to serve as a site for actin filament anchoring as part of 
the sarcomere but is also known to be a site where is there is an enrichment of sarcomeric 
mRNA and ribosomes. Unlike translocation of ribosomes to the endoplasmic reticulum, 
ribosome localization to the Z-disk is not due to a translation of a peptide sequence that 
causes the ribosome to translocate. We know this because even in the presence of the 
translation inhibitor, cycloheximide, ribosomes and sarcomeric mRNAs remain enriched 
at the Z-disk (Lewis, Moskovitz et al. 2018). This mechanism for localized protein 
translation in striated muscle remains to be elucidated. Given striated muscle has some of 
the largest proteins within the cell, it is not surprising that it would be more energetically 
favorable to have translation occur near the site of use.  Lewis et al noted that the pattern 
of ribosome localization, although present in post-natal mice, was a much less 
pronounced pattern then the prominent Z-disk localization observed in adult skeletal 
muscle (Lewis, Moskovitz et al. 2018). The muscle-specific expression of RPL3L, its 
increasing expression throughout post-natal development, and C-terminal differences – 
support the intriguing hypothesis that RPL3L C-termini contain the sequence by which 





1.6 Knowledge Gap 
Ribosomes are an indispensable complex of rRNA, and proteins whose composition 
varies with cellular conditions such as disease state, cellular stress, developmental stage, 
and tissue type. Striated muscle has a unique ribosomal protein, RPL3L, that is 
differentially expressed during post-natal development and adult muscle hypertrophy. 
The extent of conservation of RPL3L indicates a specialized function that cannot be 
compensated for by the ubiquitous RPL3. There are currently no published studies on the 
physiological, or protein translation implications, on the role of RPL3L in cardiac 
function and translation. The purpose of the research described in this dissertation, is to 
address these gaps in knowledge with the hope of shedding light on the role of RPL3L in 






CHAPTER 2. LOSS OF CARDIAC SPECIFIC RIBOSOMAL PROTEIN L3-LIKE HAS MODEST 
EFFECTS ON THE CARDIAC TRANSLATOME 
 
2.1 Introduction 
The function of the ribosome is to translate messenger RNA (mRNA) into protein 
making the ribosome indispensable for cellular proliferation, differentiation and 
maintenance. The eukaryotic ribosome is made up of two subunits that contain four 
strands of rRNA and 79 ribosomal proteins (RPs). The small subunit contains 18S rRNA 
and 33 RPs and the large subunit is comprised of 5S, 5.8S and 28S rRNAs and 46 RPs 
(Ben-Shem, Garreau de Loubresse et al. 2011).  
Since the naming of the “ribosome” (ribonucleoprotein microsome) over 60 years 
ago, the ribosome has been viewed as functioning in a constitutive manner, in a 
“housekeeping” capacity without any real regulative properties (Roberts 1958, Hess and 
Oberhauser 1966). Komili and colleagues have challenged this long-standing dogma by 
proposing the concept of a “ribosome code” in which specialized classes of ribosomes 
preferentially translate select sets of mRNAs (Komili, Farny et al. 2007). The concept of 
ribosome specialization is a major paradigm shift for the field of gene regulation as it 
represents a completely new level of regulatory control – reminiscent of microRNAs 
almost two decades ago (Couzin 2002, Moss and Poethig 2002, Xue and Barna 2012). 
The specialization of the ribosome has been proposed to occur through several 
possible mechanisms which include post-translational modifications of rRNA and/or 




Roy et al. 2016, Erales, Marchand et al. 2017, Shi, Fujii et al. 2017, Genuth and Barna 
2018, Mageeney and Ware 2019). The concept of ribosome specialization is supported by 
recent evidence showing ribosomal protein abundance and composition is more 
heterogeneous across different cell-types than was previously appreciated (Gupta and 
Warner 2014, Guimaraes and Zavolan 2016). Of particular interest was the muscle-
specific expression of ribosomal protein L3-like (Rpl3l), a paralog of the ubiquitously 
expressed Rpl3 (Van Raay, Connors et al. 1996, Gupta and Warner 2014, Guimaraes and 
Zavolan 2016). As the most ancient protein predicted to associate with the ancestral large 
ribosomal subunit, it is not surprising that RPL3 plays a fundamental role in the peptidyl 
transferase function of the ribosome; however, why striated muscle has evolved its own 
version of RPL3 remains an intriguing mystery (Kondrashov, Pusic et al. 2011, Caetano-
Anolles and Caetano-Anolles 2015). Based on studies from the Barna laboratory, we 
have developed a working model proposing RPL3L-containing ribosomes have acquired 
a specialized function that is necessary for the maintenance of sarcomeric protein 
expression (Kondrashov, Pusic et al. 2011, Xue, Tian et al. 2015). Specifically, we 
hypothesize that RPL3-like containing ribosomes preferentially associate with sarcomeric 
mRNAs to ensure robust translation. To test this hypothesis, we used RNA-seq to 
determine mRNA composition of polyribosomes (polysomes) isolated from cardiac 
muscle of WT and Rpl3l KO mice. In contrast to our hypothesis, the results from this 
analysis revealed approximately 1% of the transcripts were significantly different 
between ribosomes with or without RPL3L suggesting RPL3L has a modest influence on 






All experimental procedures performed in this study were approved by the 
University of Kentucky Institutional Animal Care and Use Committee. The Rpl3l-/- KO 
mouse (C57BL/6 background) was generated by Ingenious Targeting Laboratory (see 
Fig. 2A). A 9.3 kb genomic DNA fragment was used to construct the targeting vector 
which was subcloned from a positively identified C57BL/6 BAC clone (RP23-124B17). 
The region was designed such that the long homology arm (LA) extends ~5.64 kb from 
the 3´ end of the FAST (Flexible Accelerated STOP Tetracycline Operator-Knockin) 
cassette with the short homology arm (SA) extending approximately 3.66 kb from 5´ end 
of the FAST cassette (Tanaka, Ahmari et al. 2010). The FAST cassette was flanked by 
two loxP sites and consists of a PGK/EM7-Neo-pA sequence, a FRT-flanked stop 
cassette and a Tet operator combined with a CMV minimal promoter sequence. The 
FAST cassette was followed by the prototype Kozak sequence (GCCACC) which was 
placed immediately upstream of the endogenous ATG initiation site of Rpl3l gene. The 
targeting vector was confirmed by restriction analysis and sequencing after each 
modification. The boundaries of the two homology arms were confirmed by sequencing 
with P6 and T73 primers that read through both sides of the backbone vector into the 
genomic sequence. The FAST cassette insertion was confirmed by sequencing with 
BOSO SQ1, LAN1 and BOSO SQ2 primers. BOSO SQ1 and LAN1 sequencing 
confirmed the 5´ genomic sequence/FAST cassette junction. BOSO SQ2 sequencing 
confirmed the 3´ FAST/genomic sequence junction. Homologous recombination was 




Heterozygous Rpl3l+/- mice were bred to generate KO and WT littermates and housed in 
a humidity- and temperature-controlled facility, maintained on a 14:10 hour light-dark 
cycle with food and water ad libitum. Mice were euthanized using carbon dioxide 
followed by cervical dislocation. 
 
2.2.2 RNA Isolation 
Total RNA was isolated from the ventricles using Trizol reagent (ThermoFisher 
Scientific, Waltham, MA USA) and QuickRNA mini-prep kit plus (Zymo Research, 
Irvine, CA USA) according to the manufacturer’s protocol. Immediately upon euthanasia, 
the heart was excised, and isolated ventricles were minced and then homogenized using a 
Bullet Blender (Next Advance, Troy, NYUSA) and 1 mm zirconia beads (BioSpec 
Products, Bartlesville, OK USA). Total RNA concentration and purity was determined by 
measuring the optical density (230, 260, and 280 nm) with a Nanodrop 1000 
spectrophotometer (ThermoFisher Scientific, Waltham, MA USA). 
 
2.2.3 RT-PCR 
Complementary DNA was generated from 500 ng of total RNA using the 
SuperScript IV Reverse Transcriptase (ThermoFisher Scientific, Waltham, MA USA). 
TaqMan Fast Advanced Master Mix and TaqMan probes (Rpl3 Mm02342628_g1, Rpl3l 
Mm00481336_g1, and Gapdh Mm99999915_g1) were used for real-time PCR (Thermo 
Fisher Scientific, Waltham, MA USA). The 2^(-ΔΔCT) was calculated using Gapdh to 




2.2.4 Western Blot 
Frozen heart samples were homogenized in RIPA buffer (50m Tris HCl pH 7.4, 
1% Triton X100, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA, 
50 mM NaF) with Halt Protease Inhibitor Cocktail (ThermoFisher, Waltham, MA USA). 
Protein concentration was measured using DC Protein Assay (Bio-Rad, Hercules, CA 
USA). Thirty micrograms of whole-cell homogenate samples were prepared for SDS-
PAGE by boiling for 5 min in SDS sample buffer (50mM Tris-HCl pH 6.8, 10% glycerol, 
2% SDS, 0.02% bromophenol blue, 1% β-mercaptoethanol). Following SDS-PAGE, 
protein was transferred onto nitrocellulose membrane (Bio-Rad, Hercules, CA USA). 
Membranes were blocked with 5% milk in TBS-T (TBS, 0.1% Tween-20) for 1 hr and 
then incubated overnight at 4 °C with primary antibody. Primary antibody dilutions were 
as follows: RPL3 rabbit anti-mouse 1:2000 (Abcam ab228638, Cambridge, MA USA); 
RPS6 rabbit anti-mouse 1:5000 (Abcam ab40820, Cambridge, MA USA); RPL3L rabbit 
anti-mouse 1:2000 was generated by ThermoFisher Scientific using peptide sequence 
GPQKKHLEKEKPETLGNM. For analysis of knockout, membranes were washed in 
TBS-T and then incubated for 1 hr at room temperature with a goat anti-rabbit secondary 
antibody conjugated to 680nm fluorophore (ThermoFisher, Waltham, MA USA). 
Fluorescent intensity was measured using the Licor Odyssey instrument with band 
intensity quantified using ImageJ. For analysis of RPL3 and RPL3L expression during 
post-natal development membranes were blotted with 1:2,000 RPL3 (ab228638, Abcam, 
Cambridge, MA USA), 1:2,000 RPL3L (described above) and 1:5,000 RPS6 (Cat #2217, 
Cell Signaling, Danvers, MA USA) in 5% BSA with TBS-T overnight at 4 °C. 




horseradish peroxidase at a dilution of 1:10,000 (ThermoFisher Scientific, Waltham, MA 
USA). Luminol enhancer (ThermoFisher Scientific, Waltham, MA USA) was used to 
induce chemiluminescence which was detected using CL-X Posure™ film (ThermoFisher 
Scientific, Waltham, MA USA). 
 
2.2.5 Polysome Fractionation 
Polysome fractionation was performed as described by Garelick and colleagues 
with minor modifications (Garelick, Mackay et al. 2013). Briefly, the lower half of the 
ventricle was cut to ensure no atrial tissue was excised, then flash frozen in liquid 
nitrogen and pulverized while on dry ice with a sterile razor blade. The tissue was then 
homogenized with lysis buffer (1.5mM KCl, 2.5mM MgCl2, 5mM Tris, pH 7.5; 50 mg 
tissue/ml buffer) using a Dounce homogenizer with 20 strokes on ice. Samples were 
incubated on ice for 5 min and incubated an additional 5 min with intermittent mixing by 
inversion following the addition of 0.27% deoxycholate and 0.56% Tween-20. Samples 
were then centrifuge at 6,000 g for 15 min at 4 ºC.  Seven and a half milligrams of protein 
(~ 600ul) of supernatant was layered onto a pre-chilled 20-50% linear sucrose gradient 
and centrifuged at 40,000 g for 3 hrs at 4 ºC in a Beckman SW40Ti rotor. Gradients were 
fractionated while monitoring absorbance at 254nm with Gradient Station System 
(BioComp Instruments, Fredericton, NB, Canada). 
 
2.2.6 RNA-sequencing and Bioinformatics 
Samples from polysome fractionation containing ≥2 ribosomes were combined, and 




QuickRNA mini-prep kit plus (Zymo Research, Irvine, CA USA) according to the 
manufacturer’s protocol. Library preparation and RNA-Seq was performed by Novogene 
Co. Ltd (Beijing, China). Samples of 150 bp paired end reads with >20M reads were 
checked for quality and filtered based on read quality to eliminate low quality, low 
complexity reads (Phred <30, GC content ~50%). We also filtered and discarded rRNA, 
tRNA and mtRNA contaminants with adaptor sequences removed. Reads were then 
aligned with STAR RNA aligner allowing for 2 mismatches (Dobin et al. 2013). Reads 
that did not map uniquely were discarded and uniquely mapped reads were quantified to 
annotation model (mm10) and then normalized to sequence depth using transcripts per 
million (TPM). To account for technical variability across samples within a group, 
transcript abundance was normalized to the geometric mean of four mRNAs (Vcp, Rps6, 
Rpl38 and Gapdh whose expression was show to not be different between WT and KO in 
RT-PCR experiments (data not shown). To minimize the influence that transcript 
abundance can have on translation, we removed any mRNAs that showed a significant 
difference between WT and KO as assessed by RNA-seq of whole-cell lysate RNA. To 
determine fold- enrichment for each mRNA in polysomes, the KO ratio of 
translation/transcription was divided by WT ratio of translation/transcription for each 
mRNA.  
2.2.7 Cardiomyocyte dispersal 
Single ventricular cardiomyocytes were enzymatically isolated following a 
modified AfCS protocol PP00000125 as previously described (O'Connell 2002). In brief, 




coagulation. Mice were anesthetized with Ketamine+Xylene (90+10mg/kg), and the 
hearts were rapidly excised and retrogradely perfused at 3ml/min and 37 °C for 4-8 
minutes with a calcium free bicarbonate-based buffer (113mM NaCl, 4.7mM KCl, 0.6 
mM KH2PO4, 1.2m MgSO4, 0.6mM NaH2PO4, 5.5mM glucose, 12mM NaHCO3, 10mM 
KHCO3, 10mM HEPES, and 30mM taurine). The perfusion buffer was gassed with 95% 
O2 and 5% CO2 and warmed to 37 ˚C for at least 30 minutes before use. Enzymatic 
digestion buffer was made using the above buffer and adding 0.25mg/ml liberase 
Blendzyme (Roche) and 12.5uM CaCl2, this buffer was then used to perfuse the heart for 
about 13-18 minutes on a Langendorff apparatus until the heart was swollen and pale in 
color. The heart was then cut from the cannula the ventricles were placed in a dish 
containing stop buffer (perfusion buffer supplemented with 10% FBS and 12.5ul CaCl2) 




2.2.8 Transverse Tubules 
Dispersed cardiomyocytes were incubated for 5 minutes with Di-8-ANEPPS 
(ThermoFisher D3167) for visualization of t-tubules. Imaging was performed on a Live 5 
(Zeiss) live cells scanning microscope with a final magnification of 100x. Transverse 
tubule images were analyzed using the AutoTT software program in ImageJ (Guo and Song 
2014). 
2.2.9 Calcium Tolerance 
Dispersed cardiomyocytes were incubated at increasing calcium concentrations and 
then imaged on a Nikon Eclipse 6000 microscope and at 40X magnification. Imaging was 
repeated one hour later. For analysis, the person who quantified live cells was blinded to 
genotype. Live cells were quantified based off of morphological characteristics with typical 
shaped cells (rectangular, ridged looking structure) considered live cardiomyocytes. 
Percent alive was calculated using initial live cells/final live cells for each condition. 
2.2.10 Gene Ontology 
mRNAs that were differentially translated or differentially spliced were uploaded 
from the gene list to DAVID Bioinformatics Resources 6.8, Functional Annotation. Using 







Unless stated otherwise, unpaired Student’s t-test was performed to determine if 
significant (p < 0.05) difference existed between WT and KO genotypes for the 
dependent variable under consideration. Area under the curve analysis was used to 
determine if there were differences in polysome profiles. 
 
2.3 Results 
2.3.1 RPL3 and RPL3L Expression During Post-natal Development 
In skeletal muscle, Rpl3l mRNA expression was reported to gradually increase 
during post-natal development (Cheng and Porter 2002). To determine if a similar pattern 
of expression occurs in the heart, we performed qPCR and Western blot analyses to 
measure Rpl3l mRNA and protein, respectively, during post-natal development. As 
shown in Fig. 1A, Rpl3l mRNA expression was undetectable at post-natal day 1 (P1) and 
then gradually increased throughout post-natal development to P21; alternatively, its 
paralog, Rpl3, had peak expression at P1 and then progressively decreased through post-
natal development with the lowest expression at P21. Next, we performed Western blot 
analysis to determine if the changes in Rpl3l and Rpl3 mRNA expression during post-
natal development were reflected at the protein level. As shown in Fig. 1B, we observed 
the same general pattern of expression in RPL3L and RPL3 during post-natal 
development as we found with their respective mRNA. The expression of RPS6 




observed changes in RPL3L and RPL3 were not driven by changes in ribosome content 




Figure 1: Up-regulation of Rpl3l in the heart during post-natal development.  
A, qPCR analysis showed progressive increase in Rpl3l mRNA starting post-natal day 1 
(P1) with peak expression at P21; paralog Rpl3 mRNA expression showed the opposite 
pattern with peak expression at P1 and lowest at P21. B, Western blot analysis showed 
quantitatively similar pattern of RPL3L and RPL3 expression as observed with respective 
mRNA. Data (n=3) are presented relative to P21 for Rpl3l and P1 for Rpl3. 
 
2.3.2 RPL3L KO Strategy  
A schematic of the targeting construct used to inactivate the Rpl3l gene is shown 
in Fig. 2A. A FAST cassette, containing a transcriptional “STOP” sequence, was inserted 




Heterozygous Rpl3l+/- breeding pairs were established to generate Rpl3l-/- KO and 
Rpl3l+/+ WT littermates in roughly equal numbers indicating loss of Rpl3l expression 
was not embryonic lethal. qPCR confirmed Rpl3l mRNA expression was significantly 
reduced by 75% in the KO compared to WT while Rpl3 mRNA expression was 
unchanged in the KO (Fig. 2B-C). As shown in Fig. 2D-E, Western blot analysis revealed 
at the protein level, RPL3L expression was significantly reduced by ~90% in the KO in 









Figure 2: Effective knockdown of RPL3 expression in the heart. 
Rpl3l genetic KO model contains a stop cassette to interrupt expression of rpl3l mRNA 
production (A). rtPCR of the KO indicates that RPL3L is ~75% reduced when compared 
to the WT (B). Western blot analysis demonstrates that RPL3L is significantly reduced in 
the hearts of KO mice (C & D, p < 0.01). Student t-test were used to determine 
significance. N=3.  
 
 
2.3.3 Translational Enrichment 
To test our hypothesis that RPL3L-containing ribosomes would preferentially 
translate sarcomeric transcripts (in comparison to RPL3-containing ribosomes of KO 




and KO whole-cell cardiac lysates. Prior to polysome fractionation, a portion of the 
whole-cell lysate was set aside for RNA-seq to determine the WT and KO cardiac 
transcriptome. As presented in Fig. 3A, polysome abundance was qualitatively similar 
between WT and KO groups. Providing confidence in the polysome isolation, the 25 
most abundant polysome transcripts in cardiac muscle were either striated muscle-
enriched mRNAs (Myl2, Mb, Tnnc1, Tnnt2) or mitochondrial mRNAs (Cox7a1, Cox8b, 
Cox4i1, Atp5j2); however, there was no significant difference in the polysome abundance 
of sarcomeric transcripts between WT and KO groups, contrary to our hypothesis (see 
Table 1). We did identify 216 transcripts whose polysome abundance was significantly 
different between WT and KO groups (see Supplemental Table 1 in the Appendices). Of 
these transcripts, 68 transcripts were significantly more abundant in WT whereas 148 
transcripts were significantly more abundant in the KO. For the significantly different 
transcripts, Fig. 3B shows the 21 most abundant transcripts, presented as relative to WT; 
however, the abundance of these mRNAs was very low with the majority of the 
transcripts below 150 TPM. Gene ontology of those polysome transcripts more abundant 
in WT revealed enrichment for mRNAs involved with endoplasmic reticulum function. 
As shown in Fig. 3C, for polysome transcripts that were more abundant in the KO, gene 
ontology analysis showed the genes with the highest enrichment of ~3-fold were involved 
with RNA  





Figure 3 Modest differences in heart polysome composition between RPL3L KO and 
WT. 
A, KO and WT heart polysome profiles were similar with no difference in polysome 
abundance as assessed by area under the curve analysis. B, mRNAs with highest 
polysome enrichment presented relative to WT have low level of expression. C, Gene 






A primary determinant of whether or not a transcript is translated is the 
abundance of the transcript (Li, Bickel et al. 2014, Csardi, Franks et al. 2015). We 
performed whole-cell RNA-seq to identify and, subsequently remove, any transcripts that 
were differentially expressed between WT and KO groups (see Supplemental Table 2 of 
the Appendices), in an effort to minimize the chance that a difference in polysome 
transcript abundance was driven by a difference in transcript abundance between WT and 
KO. Having the whole-cell transcriptomic data, we next wanted to determine the 
relationship between the transcriptome and the translatome for each mRNA that was not 
differentially expressed between WT and KO. As expected, transcript abundance and 
polysome transcript abundance were highly correlated; however, unexpectedly, KO 
showed a significantly higher correlation than WT (Fig 4). This finding suggests in WT 
cardiac muscle, there is some factor(s), or lack of mRNA selectivity influencing 
translation besides transcript abundance, though our findings indicate it is likely not 






Figure 4: Transcript abundance is primary determinant of translation. 
The relationship between translation (polysome transcript abundance) and transcription 
(whole cell transcript abundance) is highly correlated (WT, R2=0.74 vs KO, R2=0.94). 
The higher correlation in KO suggests an inhibitory factor(s), or a lack of mRNA 




2.3.4 Differential Splicing 
To investigate the possibility that alternative translation of mRNAs that are 
involved in mRNA splicing and RNA binding we utilized polysome RNA sequencing data 
and a software designed to detect splicing changes in replicate RNA sequencing. We found 
that there were 825 mRNAs exhibiting differential splicing events between WT and KO. 
Of those splicing events, 729 were alternative exon usage, and 96 were mutually exclusive 
exon usage. Gene ontology of differentially spliced mRNAs that exhibited differential 
splicing in KO showed an increase in mRNAs related to mitochondria, transit peptide, 
transport, protein transport, and oxidoreductase (Fig. 5). However, the top 3 mRNAs that 
showed reduced alternative splicing in KO were Neuronatin (Nnat), Aspartate beta-
hydroxylase (Asph), and myotonic dystrophy protein kinase (Dmpk), all of which have 










Figure 5: Gene ontology of differentially spliced mRNAs.  
Gene ontology of differentially spliced mRNAs showed enrichment in mRNAs that are 
related to mitochondria, transit peptide, transport, protein transport, and oxidoreductase.  











2.3.5 Calcium Handling 
Because the top 3 most differentially spliced mRNAs were all involved in calcium 
homeostasis, we wanted to investigate calcium handling to see if these changes were 
sufficient to cause disruption in calcium homeostasis. We began by looking at calcium 
transients of dispersed cardiomyocytes before and after administration of isoproterenol. 
We found that while WT mice showed normal calcium transients before, and an 
appropriate response to isoproterenol cardiomyocytes from the KO all dying during or prior 
to data collection (n=5, data not shown). Given this unexpected finding, we wondered if 
the death of KO cardiomyocytes could be due to alterations in calcium handling. To 
investigate this possibility, we dispersed cardiomyocytes and titrated in varying levels of 
calcium. We found that while the WT mice had the highest level of survival at 
physiological levels of calcium, KO cardiomyocytes had the highest survival at very low 
levels of calcium and had increasing cell death as calcium concentration increased to 



























Figure 6: KO cardiomyocytes show an increase in calcium sensitivity. 
KO cardiomyocytes showed a decrease in survival with increasing amounts of calcium 
with the lowest level of survival at physiological levels of calcium. Data are presented as 
mean +/- SD (n=3) with asterisk denoting significance (p<0.05) between WT and KO 




2.3.6 Transverse Tubules 
Transverse tubules (t-tubules) are invaginations of the sarcolemma that allows for 
concerted release of calcium from the sarcoplasmic reticulum in response to depolarization. 
During overload and in certain pathological conditions t-tubules can become disrupted due 
to ventricular remodeling. We wanted to know if altered calcium tolerance seen in KO 
mice could be due to disruption of t-tubules. To that end, we dispersed ventricular 
cardiomyocytes and imaged t-tubules. We found that t-tubules of KO mice were 
significantly disrupted when compared to WT (Fig. 7 A,B). 
 
Figure 7: T-tubules of RPL3L mice show a decrease in regularity. 
Visual inspection of dispersed ventricular cardiomyocytes of KO mice exhibited lower t-
tubule regularity than the WT. Quantification of t-tubule regularity via the program 
AutoTT revealed that the t-tubules were significantly more disrupted in the KO mice 
compared to WT. Data are presented as mean +/- SD (n=4) with asterisk denoting 





2.4.1 Summary of Findings 
The major finding of the study is that the loss of Rpl3l had a minor effect on the 
cardiac translatome, the abundance and/or composition of transcripts translated by the 
ribosome. While we did detect differences in the abundance of transcripts being actively 
translated between WT and KO, it represented only ~1% (216/16,643) of the translatome 
which consisted of low abundant transcripts, being 150 TPM and less. Using gene 
ontology, we found that of the mRNAs that were differentially translated, many of them 
showed enrichment in splicing proteins. Despite the low level of translation of these 
proteins, we found that splicing was significantly different among WT and KO mice and 
that the top 3 most differentially spliced mRNAs all contribute to calcium homeostasis.  
Additionally, we found that dispersed ventricular cardiomyocytes show altered calcium 
homeostasis and disrupted t-tubules.  
 Most importantly, the results of the study do not support our hypothesis that 
RPL3L-containing ribosomes preferentially translate sarcomeric transcripts. In fact, we 
found no difference in the polysome abundance of any sarcomeric transcript between WT 
and KO.  
 
2.4.2 Ribosome Specialization 
The concept of ribosome specialization was formalized by Komili and coworkers 
in their proposal of a ribosome code in which specialized classes of ribosomes 
preferentially translated select sets of mRNAs (Komili, Farny et al. 2007). Support for the 




preferentially associated with Hox mRNAs through a 5'-UTR mediated mechanism 
(Kondrashov, Pusic et al. 2011, Xue and Barna 2012). Although additional evidence 
continues to accumulate supporting the concept of ribosome specialization based on 
ribosome heterogeneity, concerns have been raised regarding the use of artificial systems 
to manipulate RP levels and the possibility that the observed difference in the translation 
of distinct mRNA classes may be accounted for by a change in ribosome abundance 
(Genuth and Barna 2018, Ferretti and Karbstein 2019). 
 
2.4.3 Translational Enrichment 
A limitation of current study is we did not isolate ribosome-protected mRNA 
fragments as done with traditional Ribo-seq but rather isolated the full transcript, in 
theory, associated with the ribosome, i.e., actively being translated. As a result, we were 
unable to distinguish a transcript that was being highly translated, associated with 4-5 
ribosomes, from a transcript having a lower level translation, associated with two 
ribosomes. So, while we did not detect a difference in the abundance of sarcomeric 
transcripts being actively translated in cardiac tissue between WT and KO mice, the 
possibility remains that the level of translation of a particular sarcomeric mRNA might in 
fact be different between WT and KO. 
2.4.4 Calcium Homeostasis 
Calcium homeostasis is imperative for proper cardiac functioning due to its 
central role in excitation-contraction coupling. Differential splicing of mRNAs that are 




response. Three of the most differentially spliced mRNAs are all implicated in calcium 
homeostasis: Nnat, Asph, and Dmpk. While the role of Nnat in cardiac tissue has not been 
elucidated, it has high sequence homology to phospholamban and overexpression of Nnat 
has been shown to increase intracellular calcium and cause endoplasmic reticulum stress 
in cultured adipocytes and neuronal cells (Suh, Kim et al. 2005, Sarkozy, Zvara et al. 
2013, Sharma, Mukherjee et al. 2013). Asph undergoes extensive alternative splicing and 
gives rise to junctin and junctate, both of which play a role in calcium homeostasis 
(Gyorke, Hester et al. 2004, Hong, Kwon et al. 2008). In cardiomyocytes junctin forms a 
complex with triadin, calsequestrin and the ryanodine receptor (Zhang, Kelley et al. 
1997). The association of this complex confers luminal calcium sensitivity to the 
ryanodine receptor (Gyorke, Hester et al. 2004). Junctate is also plays a role in calcium 
homeostasis by regulating agonist induced calcium entry into the cytoplasm and 
stabilizing the connection between the plasma membrane and the sarcoplasmic reticulum 
(Treves, Franzini-Armstrong et al. 2004). Dmpk is a gene that is associated with 
myotonic muscular dystrophy, a disease marked by progressive conduction defects and 
ventricular arrhythmias. Dmpk KO cardiomyocytes exhibited increased contractility and 
increase in intracellular calcium through an unknown mechanism (Pall, Johnson et al. 
2003). While speculative at this time, the splicing differences observed in any of these 
three proteins could affect calcium handling and contribute to the t-tubule morphological 
changes seen in ventricular cardiomyocytes of Rpl3l KO mice. 
2.4.5 Possible Roles of RPL3L and Future Directions 
The findings from our study indicate that RPL3L has a modest impact on which 




striated muscle have its own version of Rpl3? While the findings of the current study 
indicate no major preference for a distinct class of mRNAs, RPL3L-containing ribosomes 
might have altered function such that processivity and/or fidelity might be different 
compared to RPL3-containing ribosomes. Given that striated muscle transcripts, such as 
titin, nebulin and dystropin, are the largest proteins in the body, could it be that RPL3L 
slows ribosome processivity thereby increasing the fidelity of translation (Mordret, 
Dahan et al. 2019)? Evidence from Duchenne muscular dystrophy in which Rpl3l is 
replaced by Rpl3, mimicking our Rpl3l KO, reported enhanced translation in skeletal 
muscle of patients compared to control subjects (Ionasescu, Zellweger et al. 1971). One 
explanation for this curious finding is that RPL3L-containing ribosome (of control 
subjects) move more slowly during translation thereby increasing fidelity, though the 
difference in the rate of translation could also be accounted for by differences in the rate 
of initiation and/or termination. An important focus of future studies will be investigating 
if Rpl3l alters ribosome function (translation initiation, fidelity and termination) with the 
hope that a better understanding of Rpl3l function will reveal fundamental insight into 






CHAPTER 3. LOSS OF VENTRICULAR- SPECIFIC RIBOSOMAL PROTEIN RPL3L ENHANCES 
RESPONSE TO ACUTE ADRENERGIC STIMULATION 
 
3.1 Introduction 
3.1.1 Atrial Fibrillation 
Atrial fibrillation (AF) is a condition in which chronic irregular electrical activity 
leads to inefficient filling of the ventricles. The sinoatrial node (SAN), a group of cells 
located in the wall of the right atrium, initiates and regulates the heartbeat. Under certain 
disease conditions the SAN may depolarize irregularly leading to aberrant electrical 
activity, which in turn can give rise to atrial fibrillation (Wijffels, Kirchhof et al. 1997, 
Fareh, Villemaire et al. 1998, Allessie, Ausma et al. 2002, Dobrev and Ravens 2003, 
Nattel, Maguy et al. 2007). AF has several co-morbid conditions including heart failure, 
stroke and myocardial infarction (Lin, Wolf et al. 1996, Soliman, Safford et al. 2014, 
Vermond, Geelhoed et al. 2015, Wijesurendra, Liu et al. 2018). The underlying 
conditions that can give rise to AF are multifactorial and may include contributions from 
genetics in about 30% of cases (Roberts 2006), or from other diseases (Fox, Parise et al. 
2004, Abdulla and Nielsen 2009, Lubitz, Ozcan et al. 2010, Lubitz, Yin et al. 2010, 
Thorp, Owen et al. 2011).  
 
3.1.2  RPL3L Tissue Specificity  
The ribosome is the molecular machine responsible for translating mRNA into 




There are a few instances in which a ribosomal protein has a paralog which often shows 
tissue-specific expression and appears to be functionally distinct (Rotenberg, Moritz et al. 
1988, Popescu and Tumer 2004, Komili, Farny et al. 2007, Wong, Li et al. 2014, 
Guimaraes and Zavolan 2016). One such tissue-specific paralog is RPL3L which is only 
expressed in striated muscle, while the canonical paralog, Rpl3 is expressed ubiquitously 
(Chaillou, Zhang et al. 2016). Recently, a genome-wide association study identified 
mutations in Rpl3l gene which were associated with a higher incidence of AF 
(Thorolfsdottir, Sveinbjornsson et al. 2018). 
 
3.1.3 Knowledge Gap 
The purpose of this study was to investigate the functional role of Rpl3l in the 
heart. Both echocardiography and electrocardiography showed no obvious differences in 
cardiac function or electrical activity, respectively, of Rpl3l KO mice compared to WT 
littermates. qPCR, Western blot, scRNA-seq and mass-spectrometry analyses confirmed 
Rpl3l was only expressed in the ventricles and not the atria or the SAN of WT mice. 
These findings show that Rpl3l is the first-known ventricular specific ribosomal protein 
and further suggest that the association of Rpl3l variants and AF maybe due to a 
ventricular pathology which promotes AF (Ehrlich, Nattel et al. 2002, Vermes, Tardif et 




3.2 Materials and Methods 
3.2.1 Animals 
All experimental procedures involving animals were approved by the University 
of Kentucky Institutional Animal Care and Use Committee. Heterozygous Rpl3l+/- mice 
(previously described in Chapter 2, Fig. 2A) were bred to generate KO and WT 
littermates and housed in a humidity- and temperature-controlled facility, maintained on a 
14:10 hour light-dark cycle with food and water ad libitum. Male mice, 3-7 months of 
age were used in the described studies and euthanized by carbon dioxide asphyxiation 
followed by cervical dislocation.  
 
3.2.2 RNA Isolation 
Total RNA was isolated from atrial and ventricular tissues using Trizol reagent 
(ThermoFisher Scientific, Waltham, MA USA) and QuickRNA mini-prep kit plus (Zymo 
Research, Irvine, CA USA) according to the manufacturer’s protocol. Ventricles and atria 
were isolated, minced with scissors, and homogenized using a Bullet Blender (Next 
Advance, Troy, NYUSA) and 1 mm zirconia beads (BioSpec Products, Bartlesville, OK 
USA). Total RNA concentration and purity were assessed by measuring the optical 
density (230, 260, and 280nm) with a Nanodrop 1000 spectrophotometer (ThermoFisher 





3.2.3 RT-PCR Analysis 
Complementary DNA was generated from 500 ng of total RNA using the 
SuperScript IV Reverse Transcriptase (ThermoFisher Scientific, Waltham, MA USA). 
TaqMan Fast Advanced Master Mix and TaqMan probes (Rpl3 Mm02342628_g1, Rpl3l 
Mm00481336_g1, and Gapdh Mm99999915_g1) were used for real-time PCR (Thermo 
Fisher Scientific, Waltham, MA USA). The 2^(-ΔΔCT) was calculated using Gapdh as 
the control and normalized to Rpl3l or Rpl3 for ventricle or atria analysis, respectively.  
 
3.2.4 Western Blot Analysis 
Frozen ventricle and atrium samples were homogenized in RIPA buffer (50m Tris 
HCl pH 7.4, 1% Triton X100, 0.5% Na deoxycholate, 0.1% SDS, 150 mM NaCl, 2 mM 
EDTA, 50 mM NaF) with Halt Protease Inhibitor Cocktail (ThermoFisher, Waltham, MA 
USA). Protein concentration was measured using DC Protein Assay (Bio-Rad, Hercules, 
CA USA). Thirty micrograms of protein homogenate samples were prepared for SDS-
PAGE by boiling for 5 min in SDS sample buffer (50mM Tris-HCl pH 6.8, 10% glycerol, 
2% SDS, 0.02% bromophenol blue, 1% beta-mercaptoethanol). Following SDS-PAGE, 
protein was transferred onto nitrocellulose membrane (Bio-Rad, Hercules, CA USA). 
Membranes were blocked with 5% milk in TBS-T (TBS, 0.1% TWEEN 20) for 1 hr and 
then incubated overnight at 4 °C with primary antibody. Primary antibody dilutions were 
as follows: RPL3 rabbit anti-mouse 1:2000 (Abcam ab228638, Cambridge, MA USA); 
RPL3L rabbit anti-mouse 1:2000 was generated by ThermoFisher Scientific using 
peptide sequence GPQKKHLEKEKPETLGNM. Following overnight incubation, 




a goat anti-rabbit secondary antibody conjugated to 680nm fluorophore (ThermoFisher, 
Waltham, MA USA). Fluorescent intensity was measured using ChemiDoc MP Imaging 
System (Hercules, CA USA) and band intensity was quantified using ImageJ. 
Fluorescence intensity of bands was normalized to Ponceau S staining (Biotium Inc, 
Fremont, CA, USA).  
3.2.5 Single-cell RNA-Sequencing Analysis 
Fastq files from single-cell RNA-sequencing (scRNA-seq) analysis of isolated 
mouse sinus atrial node (SAN) tissue, as reported by Linscheid and colleagues, were 
retrieved from NCBI Gene Expression Omnibus (accession number GSE130710, sample 
H4). Cell Ranger 3.1 pipeline (10X Genomics, USA) was used for read alignment using 
the mouse mm10 release 93 reference genome modified to include pre-mRNA. Cell calls 
were made using default parameters for Cell Ranger. Unique molecular identifier counts 
for all partitions identified as cells were greater than 2150. The re-analyze function in 
Cell Ranger was used to eliminate cell clusters enriched in mitochondrial reads as 
described on the 10x website (https://kb.10xgenomics.com). Only one cluster was 
eliminated because of enrichment in mitochondrial genes (the top most differentially 
expressed genes were mitochondrial genes indicating that these RNA seq reactions were 
from dead cells). The remaining 5,472 cells were used for analysis. K means clustering 
was used to define clusters. In Loupe Cell Browser, cells containing either Rpl3 or Rpl3l 
were selected for further analysis to compare gene expression between the two cell 
populations. Genes with low average expression (<1 count on average) were discarded. 
For cell type determination, we used the genes that were found by Linscheid et al. to be 




cluster, the cluster had to have all or most of the following genes as their most 
differentially expressed genes: sinus node myocytes: Myh6, Ctnna3, Ryr2, Rbm20, Dmd, 
Ttn, and Tbx5; fibroblasts: Col1a1, Fbn1, Ddr2, Lama2, Lamc1, Pcsk6, Gpc6, Mecom, 
Rbms3, and 4930578G10Rik; macrophages: Maf, F13a1, Cd163, C3ar1, P2yr6, Mrc1, 
Mgl2, Adgre1, and Dab2; vascular endothelial: Ptprb, Icam1, Vwf, Ldb2, Pecam1 and 
Cdh13; adipocytes: Ucp1, Cidea, Prdm16, Pparg, Lep, Ghr, Slc1a5, Pde3b, Sorbs1, 
Acsl1, and Adopr2; endocardial: Npr3, Cdh13, Engm Hmcn1 and Gmds and epicardial 
cells: Wt1, Rbfox1, Kcnd2, Grip1, Plxna4 and Syne2. 
 
3.2.6 Quantitative Proteomics 
The mass spectrometry proteomics data was downloaded from the 
ProteomeXchange Consortium via the PRIDE repository (https://www.ebi.ac.uk/pride/). 
Dataset for mouse SAN cells (PXD008736) include 6 samples with 12 fractions per 
sample performed in technical duplicate. Raw MS data were analyzed using MaxQuant 
v1.6.8.0 (Max-Planck Institute of Biochemistry, Department of Proteomics and Signal 
Transduction, Munich, Germany). Peptide search was performed using the UniProt 
reference proteome for Mus musculus (Proteome ID UP000000589). False-discovery rate 
(FDR) was set to 1% for peptide, protein, and side decoy identification with base FDR 
calculated on delta score. Unmodified, unique and razor peptides were used for protein 
quantification to address high amino acid sequence similarity between paralogous 
proteins. All other parameters were kept at default. To ensure that sensitivity was 




HCN4 and eliminated any samples that did not exhibit a significant quantity for each of 
these proteins. The remaining samples were used to quantify RPL3 and RPL3L intensity. 
 
3.2.7 Echocardiography 
Transthoracic echocardiography was performed using the Visual Sonics 3300 
imaging system equipped with 30-MHz probe. Mice underwent transthoracic 
echocardiography, under light anesthesia (inhaled isoflurane, 1-2%), with heart rate (350-
500 beats per minute) and core temperature (37 ºC) continuously monitored.  The heart 
was visualized in 2D from modified parasternal long axis and short axis views. The left 
ventricular dimensions and calculated left ventricular ejection fraction (EF) were 
measured from the short axis M-mode display. All measurements were obtained in 
triplicate and averaged. The sonographer was blinded to animal genotype during imaging 
and analysis.  
 
3.2.8 Electrocardiography 
Mice were anesthetized by continuous isoflurane (2-4%) inhalation until 
unresponsive to paw pinch. A small abdominal incision was made and a telemetry probe 
(Data Science International, TA11ETA-F10) was implanted in the peritoneal cavity under 
aseptic conditions. The two ECG leads were secured near the apex of the heart and the 
right acromion. Mice were housed singly and given seven days to recover from the 
surgery before data collection. The implanted telemetry was used to measure core body 




weeks and subsequently analyzed on Ponemah DSI telemetry software. Ventricular rate 
represents an average of three days’ worth of data for each animal with a logging rate of 
fifteen minutes. For QRS and PR interval, a section of clean data was found during the 
inactive period and 150 individual beats were averaged for each animal. Heart rate during 
the isoproterenol challenge was obtained with a logging rate of one minute. Mice were 
monitored for one week and then were given a single injection of isoproterenol (ISO, 30 
mg/kg, USP) and then monitored for another week post-injection. Representative traces 
were taken immediately after isoproterenol injection. 
 
3.2.9 Statistics 
Unless stated otherwise, unpaired Student’s t-test was performed to determine if 
significant (p < 0.05) difference existed between WT and KO genotypes for the 
dependent variable under consideration. A two-way ANOVA was used to determine if 
there were significant differences between WT and KO genotype in heart rate in response 
to isoproterenol. A one-way ANOVA was used to determine if there was a significant 
difference in the rate of change in heart rate between WT and KO genotype following 
isoproterenol treatment and protein abundance relative to RPL3L abundance in the sinus 






3.3.1 Atria and Ventricular Expression of RPL3L 
We reported Rpl3l mRNA was approximately 2.5-fold higher than Rpl3 mRNA in 
the heart (Chaillou, Zhang et al. 2016). In light of the findings reported by Thorolfsdottir 
and coworkers that Rpl3l coding variants increased risks for atrial fibrillation we wanted 
to determine the expression levels of Rpl3l and Rpl3 in the atria and ventricles of the 
heart. qPCR analysis showed Rpl3l was significantly higher than Rpl3 expression in the 
ventricles in WT mice (Fig. 8A). In the atria, the expression pattern was the opposite to 
the ventricles, where Rpl3 expression was significantly higher than Rpl3l which was 
almost undetectable (Fig. 8B). In agreement with the mRNA expression pattern, Western 
blot analysis showed RPL3L was highly expressed in the ventricles, but almost 







Figure 8. Ventricular specific expression of RPL3L.  
A-B, qPCR analysis of ventricle samples showed Rpl3l mRNA expression was 
significantly higher than Rpl3 expression whereas in the atria, Rpl3l mRNA expression 
was significantly lower than Rpl3 expression (N=4). C, In agreement with mRNA results, 
Western blot analysis showed RPL3L expression was ventricular-specific. Data are 
expressed as mean ± SE with significant difference designated by ^ (p<0.001). 
 
3.3.2 Echocardiography and Electrocardiography 
To determine whether the loss of Rpl3l expression in the heart altered cardiac 
function, we performed echocardiography in WT and KO mice under anesthesia. We 
observed no significant difference on heart rate (Fig. 9A, p >0.05), ejection fraction (Fig. 




diastole p >0.05) between the WT and KO mice. We also observed no difference in 
calculated cardiac output, fractional shortening, left ventricular mass, left ventricular 
volume during systole and diastole, and stroke volume between the two groups (Table 1). 
To determine if the electrical activity of the heart was altered in the KO, ECG probes 
were implanted to allow for continuous recording of electrical activity. There was no 
difference between WT and KO for ventricular rates (p = >0.05, Fig. 10 A,D), QRS 
length (p = >0.05, Fig. 10 B,D) or PR interval (p = >0.05, Fig. 10 C,D). When treated 
with isoproterenol, both WT and KO mice showed a significant increase in heart rate 
(both p =<0.05, Fig. 10 E-F), but the rate of response to isoproterenol in the KO was 





Figure 9: Loss of RPL3L does not affect cardiac function. 
Echocardiography revealed no difference in cardiac function between WT and KO mice. 
A, heart rate; B, ejection fraction; C-D, left ventricular wall thickness during systole or 
diastole. Data are expressed as mean ± SE (n=10-17/genotype).   
 






Figure 10: Electrical activity of the heart in WT and KO mice.  
Electrocardiography showed no difference in A, ventricular rate; B, QRS length; and C, 
PR interval between WT and KO mice. D, representative ECG trace of WT and KO mice 
show minor variations which are typical of mouse ECGs. E, isoproterenol treatment 
significantly increased heart in both WT and KO mice. F, the rate at which heart rate 
increased was significantly greater in KO compared to WT; G, the rate of heart rate 
increase was determined by averaging the heart rate at two-minute intervals and then 
normalized to WT heart rate. Data are expressed as mean ± SE (n=4-5/genotype) with 






3.3.3 Single Cell RNA Sequencing of the SAN 
Given the enhanced response to isoproterenol in the KO, and the reported 
association of AF and Rpl3l variants, we took advantage of a recently published scRNA-
seq dataset from isolated SAN cells to determine the expression pattern of Rpl3l and Rpl3 
in the SAN (Zhang, Butters et al. 2012, Linscheid, Logantha et al. 2019). As shown in 
Fig. 11, t-distributed stochastic neighbor embedding (t-SNE) representation revealed that, 
of the 5,472 cells analyzed, only 203 were classified as sinus node myocytes based on the 
expression of Myh6, Ctnna3, Ryr2, Rbm20, Dmd, Ttn and Tbx5. In addition to these 
myocytes, five other distinct cell-types were identified including fibroblast, epicardial, 
endocardial, macrophage, adipocyte and an undefined cluster. Rpl3l transcript was only 
detected in approximately 1% (59/5472) of the cells and was not exclusive to one 
particular cell-type. Within sinus node myocytes, Rpl3l transcript was detected in ~10% 
(22/203) of the cells. However, with only ~10% of SAN cells expressing Rpl3l, its 





Figure 11: Low expression of Rpl3l in sinoatrial node. 
t-distributed stochastic neighbor embedding (t-SNE) plot of single-cell nuclear RNA-seq 
data identified seven cell clusters including myocyte, fibroblast, epicardial, endocardial, 
macrophage, adipocyte and an undefined cluster. Cells expressing Rpl3l or Rpl3 are 
indicated by blue or orange, respectively. Rpl3l transcript was detected in approximately 
1% (59/5472) of the cells and was not exclusive to one particular cell-type. Within sinus 
node myocytes, Rpl3l transcript was detected in ~10% (22/203) of the cells. 
 
3.3.4 Quantitative Proteomics 
In addition to scRNA-seq analysis, Linscheid and colleagues also performed 
quantitative proteomics of the SAN (Linscheid, Logantha et al. 2019). Given RPL3L and 
RPL3 are 78% identical at the amino acid level, we re-analyzed the proteomic dataset 
paying particular attention to unaligned reads and using a less stringent cut-off for 




abundance in agreement with Rpl3l qPCR and scRNA-seq results demonstrating 
extremely low expression of Rpl3l transcript and protein in the atria. Despite SAN 
myocytes being ~3% of the cells (as shown by scRNA-seq) of the isolated tissue, 
proteomic analysis was sensitive enough to reliably detect the SAN specific proteins, 
HCN4 and CTNNA3, indicating low abundance of RPL3L peptides was not caused by a 
lack of sensitivity (Fig. 12). 
 
Figure 12: RPL3L barely detectable in sinoatrial node. 
Quantitative proteomics showed RPL3L peptide abundance in the sinoatrial node was 0.6% 
of RPL3 peptide abundance in agreement with Rpl3l qPCR and scRNA-seq results 
demonstrating extremely low expression of Rpl3l transcript and protein in the atria. Despite 
sinus atrial node (SAN) myocytes being less than 3% of the cells (as shown by scRNA-
seq) of the isolated tissue, proteomic analysis was sensitive enough to reliably detect the 
SAN specific proteins, HCN4 and CTNNA3, indicating low abundance of RPL3L peptides 
was not caused by a lack of sensitivity Peptide intensity of RPL3, RPL3L, HCN4 and 
CTTNA3 from cells of the sinoatrial node. One- way ANOVA was used to determine 
significance of all genes compared to RPL3L with significant difference designated by # 





3.4.1 Summary of Findings 
A major finding of this study was the ventricular-specific expression of RPL3-like 
(RPL3L) in the mouse heart - a finding that agrees with human expression data (Uhlen, 
Fagerberg et al. 2015). A second major finding of the study was that the loss of Rpl3l 
expression did not affect either the function or electrical activity of the heart in adult male 
mice. Repeat analysis (with modification) of previously published scRNA-seq and 
quantitative proteomics of mouse SAN tissue, with a focus on cells expressing Rpl3l, 
revealed that Rpl3l was only expressed in ~12% of the cells analyzed and that RPL3L 
was barely detectable in SAN tissue as determine by mass-spectrometry. We conclude 
that the atrial fibrillation phenotype observed in humans with a mutation in Rpl3l is not 
due to its expression in the atria or the sinoatrial node. 
 
3.4.2  Tissue Specificity 
During the course of characterizing the polycystic kidney disease gene region, 
Burn and coworkers identified Rpl3l, a gene with 74% nucleotide sequence identity to the 
Rpl3 gene, which was subsequently shown to be exclusively expressed in skeletal muscle 
and the heart (Van Raay, Connors et al. 1996). More recent studies have confirmed the 
muscle-specific expression of Rpl3l mRNA in humans and found that of the all the 
ribosomal proteins, Rpl3l showed the highest degree of tissue-specificity (Gupta and 
Warner 2014, Guimaraes and Zavolan 2016). Proteomic analysis of human fetal (17-23 




specific protein (relative to atria expression) which also included such other proteins as 
myosin light chain 5 (Myl5), monocarboxylate transporter 1 (Slc16a1) and calcineurin-
like phosphoesterase domain-containing protein 1 (Cpped1) (Lu, Sinha et al. 2014). 
Similar to skeletal muscle during postnatal development, Rpl3l expression was 
significantly upregulated in the ventricle; in fact, from P1 thru P23, Rpl3l was second to 
Hmcn2 as the most significantly upregulated gene in the ventricle (Cheng, Merriam et al. 
2004, Talman, Teppo et al. 2018). In contrast, the expression of Rpl3 during this time 
period was down-regulated by approximately 50%, similar to what is observed in skeletal 
muscle and, more broadly, reflects the often coordinated, inverse pattern of expression 
observed between ribosomal protein paralogs (Xue and Barna 2012). 
 
3.4.3 Possible Roles of RPL3L 
Besides our earlier study describing a possible role for Rpl3l in skeletal muscle 
hypertrophy, very little is known about the function of Rpl3l; however, in contrast, the 
function of Rpl3 has been studied in great detail (Meskauskas, Petrov et al. 2005, 
Meskauskas and Dinman 2007, Russo, Esposito et al. 2013, Al-Hadid, Roy et al. 2016, 
Pagliara, Saide et al. 2016). As the first ribosomal protein predicted to interact with the 
ancestor of the large ribosomal subunit, it is not surprising then that RPL3 has a 
fundamental role in ribosome function, i.e., peptidyl transferase activity, and pre-rRNA 
processing (Meskauskas, Harger et al. 2003, Meskauskas and Dinman 2007, Poll, Braun 
et al. 2009, Caetano-Anolles and Caetano-Anolles 2015, Al-Hadid, Roy et al. 2016). 
These studies detailing the function of RPL3, raises several fundamental questions about 




ancient and fundamental ribosomal protein? What is so unique about the ventricles that 
requires them to have their own version of RPL3? Based on the high-degree of amino 
acid conservation (~80%) between RPL3 and RPL3L, it is reasonable to suggest that 
RPL3L performs similar, but distinct, functions as RPL3 (Van Raay, Connors et al. 
1996). Early work on skeletal muscle ribosomes suggested the large size of myosin 
mRNA might require unique polyribosome structure to effectively translate such a large 
protein (Breuer, Davies et al. 1964). Could it be that RPL3L alters ribosome function in 
such a way that the ribosome is able to more effectively (e.g., initiation, fidelity, and/or 
processivity) translate large mRNAs? We now know that there are much larger 
sarcomeric proteins than myosin (223 kDa) found in the ventricles, including dystrophin 
(426 kDa), nebulin (801 kDa), obscurin (832 kDa) and the largest protein in the body, 
titin (3,906 kDa). While this idea remains to be rigorously tested, the evolution of a 
ventricular-specific version of such an important ribosomal protein suggests a better 
understanding of Rpl3l function will reveal novel insight regarding translation in striated 
muscle.   
 
3.4.4 Phenotype of RPL3L KO Mice 
If Rpl3l is so important, why did we not observe a more dramatic phenotype in the 
KO mouse?  The lack of a cardiac phenotype was likely masked by compensation by 
Rpl3. RPL3 and RPL3L are ~80% identical at the amino acid level and hence it is 
reasonable to assume that these paralogs share some similar ribosomal functions, thus 
allowing RPL3 to functionally compensate for the loss of RPL3L in the KO. Although 




known in the literature, the compensation of Rpl3 for Rpl3l further highlights the 
potential limitation of using a KO strategy to study gene function. Future studies will 
require using a knockin strategy to introduce mutations into the Rpl3l gene loci, such as 
those identified by Thorolfsdottir and coworkers, to study the connection between Rpl3l 
and AF (Thorolfsdottir, Sveinbjornsson et al. 2018). Finally, another possible factor as to 
why we did not observe a more robust cardiac phenotype in the KO is the resiliency of 
the mouse. For example, diseases which are life-threatening to humans, i.e, Alzheimer’s 
disease and Duchenne Muscular Dystrophy do not dramatically affect longevity in the 
mouse. 
 
3.4.5 Possible Roles of RPL3L in Atrial Fibrillation 
The ventricular-specific expression of Rpl3l has important implications for the 
possible role that Rpl3l might have in the etiology of AF. The study by Thorolfsdottir and 
colleagues generated a great deal of interest because, unlike previous studies which had 
mostly identified non-coding sequence variants, these authors identify missense and 
splice-donor variants in Rpl3l which showed a significant association with AF 
(Thorolfsdottir, Sveinbjornsson et al. 2018). Given the ventricular-specific expression of 
Rpl3l, it is not readily apparent how mutations in Rpl3l might give rise to AF.  AF can be 
caused by either an atrial pathology (like fibrosis, remodeling, or aberrant electrical 
dysfunction) or can originate via a ventricular pathology (Grogan, Smith et al. 1992, 
Burstein and Nattel 2008, Ling, Kistler et al. 2012, McGann, Akoum et al. 2014). 
Chronic heart failure is one such ventricular pathology that leads to increased incidence 




argue that AF arises first and then leads to heart failure, Vermes et al., published a study 
which clearly showed AF often arose after ventricular dysfunction had been established 
(Vermes, Tardif et al. 2003). If left untreated, 24% of patients with ventricular 
dysfunction developed AF within 4 years (Vermes, Tardif et al. 2003). Patients with 
arrhythmogenic right ventricular pathologies also suffer high instances of abnormal 
electrical activity in the atria and atrial remodeling (Platonov, Christensen et al. 2011, 
Wu, Guo et al. 2016). Based on the findings from the current study, we speculate that the 
AF observed in patients with RPL3L mutations may reflect a ventricular pathology given 
that RPL3L protein is not detected in the atria or the SAN at physiologically relevant 
levels but is highly expressed in the ventricle. Determining how mutations in a 
ventricular-specific protein can promote AF will be an important focus for future 
research.  
An alternative theory is that a subpopulation of the SAN expresses RPL3L but 
makes up such a small fraction of cells in the SAN that the signal is insufficient for 
detection. Although the SAN is spoken about as though it is a homogenous entity, there 
are 3 major morphological variations in cells that make up the node. There are short 
spindle cells that are primarily mononucleated, elongated spindle cells that extend up to 
80um, and spider cells that are irregularly shaped (Verheijck, Wessels et al. 1998). 
Although these cell subtypes, show enrichment in regions of the SAN, they are not 
exclusive to any one area. There are also regional differences in the electrical activity of 
the SAN with cells near the periphery showing increase in upstroke velocity and 
overshoot verses the central cells show slower recovery of excitability (Kodama and 




expresses RPL3L but that the protein level of that population was too low to detect when 
incorporated with the other populations of SAN cells and non-SAN cell types. Knowing 
if RPL3L and RPL3 are differentially expressed in the cells of the sinoatrial node would 
help to inform the relevance of RPL3L mutations causing atrial fibrillation and possibly 
help elucidate the role of RPL3L.  
3.4.6 Genome Wide Association Studies 
Genome-wide association studies are valuable because if a trait is known to be 
influenced by a gene, gene variant, or set of genes, this knowledge can be used to further 
research the trait. However, not all correlated genes or gene variants are causal for any 
particular trait. Quite often there can even be reverse causal effects or confounding effects 
that prevent researchers from truly discerning important genetic traits (Zhu, Zheng et al. 
2018). While there are some models that allow researchers to better discriminate between 
correlation and causation, these methods are susceptible to a high rate of directional error 
(ie showing a causal effect rather than the loss of a gene or gene variant showing a causal 
effect) with increasing sample size (Hemani, Tilling et al. 2017). It is possible that variants 
in Rpl3l and atrial fibrillation are not causal and are mere correlations. To truly investigate 






CHAPTER 4. REFLECTIONS AND LOOKING AHEAD TO FUTURE STUDIES 
 
4.1 Reflections 
Research efforts in this dissertation were designed to investigate the role of RPL3L 
in cardiac tissue. The specific objectives were to 1) determine the expression of RPL3L 
in the heart, 2) determine if there were functional cardiac abnormalities in its absence and 
3) to determine if RPL3L associated ribosomes exhibited translational alterations.  
Although cardiac tissue is one of few organs that expresses RPL3L, its function and 
exact expression pattern in the heart has not been well documented. Understanding the 
role that RPL3L plays in cardiac function may inform molecular aspects of pathological 
processes in the heart, such as cardiac hypertrophy or the possible role of translation in 
the development of cardiac fibrosis (Hannan, Stefanovsky et al. 1996, Chothani, Schafer 
et al. 2019). The importance of the ribosome and ribosomal composition in particular, 
have historically been understudied in the heart despite the role of translation in cardiac 
hypertrophy and fibrosis through the synthesis of proteins required for both of those 
pathological processes. In an effort to better understand the role of the ribosome and 
translational processes specific to the heart we must first understand how ribosomal 





4.1.1 The Translatome 
The focus of Chapter 2 was to determine if the loss of RPL3L affected cardiac 
translation as assessed by polysome composition. I found that out of 16,643 mRNAs that 
were detected, only 216 were differentially enriched in the translating fraction indicating 
that RPL3L had a modest effect on translation in the ventricles of the heart. Interestingly, 
I found that cardiac tissue of the RPL3L KO showed a higher correlation between 
polysome transcript abundance to whole-cell transcript abundance (translatome: 
transcriptome than WT (Ch. 2, Fig. 3). This finding indicates there are likely alterations in 
translation in the KO that are not captured by the polysome fractionation. A limitation of 
polysome fractionation method I used was the inability to detect changes in translation with 
single ribosome resolution as is possible with Ribo-seq method. Traditional Ribo-seq is 
done by performing RNA sequencing on each individual, ribosome protected mRNA 
fragment. While Ribo-seq can be technically challenging, it does allow one to more 
precisely measure the level of translation for each detected mRNA. Although the technique 
I used cannot differentiate between mRNAs containing 2-4 ribosomes, from mRNAs 
containing 5+ ribosomes, it is the only way to assess the relationship between total mRNA 
and total translated mRNA. I hypothesize that if true Ribo-seq was done on the ventricles 
of KO mice, that the most differentially translated mRNAs would be transcripts that are 






4.1.2 Calcium Handling and Cardiac Function 
Investigation of the role that Rpl3l plays in calcium handling demonstrated that 
there were differences in calcium tolerance, and disrupted t-tubules in KO cardiomyocytes. 
Although we were not able to measure calcium directly we were able to demonstrate 
differences in response to increasing levels of calcium in dispersed cardiomyocytes (Ch. 2, 
Fig. 6). Interestingly, we found that the 3 mRNAs that were the most differentially spliced 
between WT and KO were involved in calcium handling: Nnat, Asph, and Dmpk. While 
these results do not definitively show a connection between splicing and calcium handling 
they point to a possible mechanism by which the WT translatome helps to regulate calcium 
homeostasis. We also looked at t-tubule morphology and found that KO mice had 
significantly more disrupted t-tubules than WT mice. Because t-tubule integrity is 
important for calcium homeostasis, this disruption in t-tubule morphology (and possibly t-
tubule integrity) could account for alterations in calcium tolerance between WT and KO 
mice.  
I also found that KO mice exhibit a heightened response to isoproterenol treatment. 
WT and KO mice showed no difference in cardiac function under resting conditions but 
when challenged with isoproterenol, KO mice had a more rapid response. Although no 
other data points to a possible mechanism by which RPL3L mice would be highly 
sensitized to isoproterenol, I speculate that calcium mishandling leads to this altered 





4.1.3 Atrial Fibrillation  
As presented in Chapter 3, I explored the possibility that RPL3L has a role in 
atrial fibrillation; however, I found that RPL3L is not expressed in the atria and the 
RPL3L KO mouse showed no signs of atrial fibrillation or any overt cardiac 
abnormalities under resting conditions. Interestingly, RPL3L KO mice exhibited a 
heightened response to the beta-adrenergic agonist, isoproterenol. I reasoned that perhaps 
the alteration in responsiveness to adrenergic stimulation might be due to loss of RPL3L 
in the sinoatrial node. To test this hypothesis, I reanalyzed previously published single-
cell RNA sequencing, and proteomic data from sinoatrial node (SAN) cells of mice. I 
found that although there were cells within the SAN that expressed RPL3L at the mRNA 
level, the same was not reflected at the protein level. Although nothing is known of 
RPL3L in the human SAN, human protein atlas confirmed that humans do not express 
RPL3L in the atria, suggesting that atrial fibrillation associated with variants of Rpl3l is 
likely due to a ventricular pathology.  
To further investigate the possible role of Rpl3l variants in the development of 
atrial fibrillation, it would be valuable to generate RPL3L mutant mice which harbored 
the different Rpl3l mutations described in humans associated with a higher incidence of 
atrial fibrillation (Thorolfsdottir, Sveinbjornsson et al. 2018).  Such a mouse model 
would help to circumvent a limitation of our RPL3L KO mouse – compensation by RPL3 
which likely masked any possible cardiac phenotype resulting from loss of RPL3L 
expression. I speculate that if an RPL3L mutant model was made, aged mice would 




4.2 Future Directions  
As with any research, answering questions only leads to more questions, and this 
project was no exception. While there is a lifetime of work that needs to be done to fully 
elucidate the role of RPL3L in striated tissue a few key experiments are listed below.  
4.2.1 Ribo-seq 
In the present work, I found that isolating the entire translational fraction to assess 
changes in polysome composition identified 216 mRNAs that were significantly different 
between WT and KO while accounting for differences in transcription. Ribo-seq, 
however, represents a more granular approach which would lead to a more robust list due 
to being able to quantify minute changes in translation. Using this technique would 
broaden our knowledge in three key ways. First, it would give us the ability to quantify 
exact number of ribosomes per mRNAs.  This information would allow us to distinguish 
between high and low transcribed transcripts as well as determine if RPL3L has any role 
in initiation, elongation and processivity of translation.  
4.2.1.1 Initiation 
Some alterations in initiation can be due to 5'-UTR motifs, but changes in 
initiation can also indicate that the ribosome itself is not competent for normal rates of 
initiation due to structural changes.  Depletion of a ribosomal protein such as RPL3L may 
cause changes in ribosome structure which affect translation initiation. I have preliminary 
data from a cell-free translation assay showing that skeletal muscle ribosomes isolated 




ribosomes. One explanation for this finding is the loss of RPL3L negatively affects the 
ability of the ribosome to effectively initiate translation.   
4.2.1.2 Elongation 
Using Ribo-seq elongation could also be assessed and possibly inform the 
function of RPL3L. For instance, ribosomes will often pause on unusual codons or mis- 
incorporate an amino acid. However, it is possible that having a specialized ribosome 
could mitigate pausing time and decrease the rate of mis-incorporation. Using Ribo-seq 
coupled to proteomics, it would be possible to inspect pause time of the ribosome on 
mRNA by statistical analysis of ribosome fragments found with a specific codon at the P 
site.  
4.2.1.3 Processivity 
In the context of translation, processivity refers to the ribosomes ability to 
continue translating without releasing from the transcript during translation of a single 
mRNA. By using Ribo-seq it would be possible to look at the location of ribosome 
protected fragments to learn about processivity rates of WT and RPL3L KO ribosomes. If 
ribosome protected fragments are found in the beginning of the message at high levels 
but then decrease along the length of the message, it is possible that the ribosome may 





4.2.2 Muscle Function 
In addition to the experiment described above a pivotal experiment would be to 
test the muscle function of WT and RPL3L KO mice. Although I did do grip strength 
testing in mice and found no significant difference between the genotypes, these results 
are confounded by 2 variables, the willingness of the mouse to hold on to the force 
transducer, and the experimenter’s consistency in force and acceleration of pull. I would 
argue that the ideal muscle function test should be done ex-vivo in skeletal muscle and the 
heart, without the additional confounding variables of pinnation angles in muscle and 
tendon elasticity. By doing this experiment in WT and KO mice, especially coupled to 
Ribo-seq, we could determine if there are translational changes that leads to loss of 
contractility. I speculate that enhanced translation of sarcomeric transcripts would be 
reflected in functional muscle testing. This hypothesis is supported by preliminary data 
indicating that RPL3L KO mice have enhanced specific force in the extensor digitorum 
longus muscle.  
4.2.3 Sinoatrial Node Subpopulations 
Chapter 3 describes the expression pattern of RPL3L in the heart and shows some 
expression of Rpl3l mRNA in the SAN; however, the expression of the RPL3L protein 
was expressed just above the level of detection. Worthwhile experiments would include a 
more detailed examination of the SAN. Although the SAN is spoken about as though it is 
a homogenous entity, there are three morphologically distinct cell types within the node, 
and there are physiological differences in electrical function in cells at the center verses 




diastolic potential were increased relative to the centrally located SAN cells. 
Alternatively, the centrally located cells of the SAN showed slower recovery of 
excitability. These electrical changes indicate that there could be some functionally 
significant, non-redundant role that both areas play and that those cells require RPL3L for 
optimal functioning. Although RPL3L protein was found in the SAN at extremely low, it 
is possible that this small amount of protein was specific to a certain cell type within the 
SAN. Such an expression pattern could explain both the connection between RPL3L 
mutations and atrial fibrillation, and the enhanced adrenergic response to isoproterenol 
















Supplemental Table 1: Genes with significantly different cardiac polysome abundance 
between WT and KO mice.  
 
Supplemental Table 1.  
Note: Values represent normalized expression to whole-cell transcript abundance 
(translatome/transcriptome) (n=3/genotype) 
Gene Symbol WT  KO  p-value 
Bzw1 2.92 6.16 0.047 
Mrpl50 2.83 4.95 0.046 
D330023K18Rik 2.65 1.5 0.023 
Sms 2.52 4.46 0.041 
Chmp5 2.2 4.59 0.046 
Fbxo22 2.13 3.6 0.037 
Rab5a 2.07 5.48 0.039 
Sf3b1 2.07 4.01 0.029 
Gbp6 2.05 4.05 0.018 
Lin52 1.99 3.1 0.049 
C1d 1.98 3.93 0.048 
Spink4 1.86 1.01 0.036 
Glrx5 1.78 1.36 0.049 
Eif4a2 1.76 3.82 0.026 
Klf4 1.75 3.07 0.043 
Ttc33 1.71 2.98 0.05 
Pnkd 1.71 1.32 0.05 
Atg10 1.69 3.84 0.024 
Zfp715 1.68 3.24 0.025 




Supplemental Table 1 (continued) 
Gene Symbol WT  KO  p-value 
Bud31 1.65 2.29 0.04 
Gpalpp1 1.61 1.33 0.037 
Hnrnpu 1.61 2.96 0.045 
Nampt 1.6 3.09 0.027 
Atcayos 1.6 0.9 0.015 
Uso1 1.55 2.9 0.042 
Paip1 1.54 3.01 0.039 
E130311K13Rik 1.51 3.15 0.033 
Pnisr 1.5 2.38 0.045 
Tex38 1.48 1 0.019 
Nupr1l 1.47 0.75 0.008 
Rab9 1.46 4.27 0.045 
Arglu1 1.46 2.17 0.05 
Gipc2 1.45 2.29 0.018 
Phkb 1.45 3.08 0.049 
Stx12 1.44 2.29 0.048 
Cav1 1.43 2.96 0.036 
AI839979 1.4 2.22 0.04 
Eif1a 1.4 2.46 0.047 
Zfp830 1.39 2.13 0.022 
Serbp1 1.38 2.45 0.042 
Ptgr2 1.38 2.56 0.046 
Adss 1.38 2.28 0.049 
Sec62 1.37 2.96 0.043 




Supplemental Table 1 (continued) 
Gene Symbol WT  KO  p-value 
Appl2 1.37 1.85 0.048 
Ranbp9 1.36 3.15 0.026 
Ublcp1 1.32 2.68 0.049 
Mrps10 1.31 1.1 0.004 
Son 1.31 1.68 0.03 
Ell2 1.3 2.63 0.037 
Hist1h1e 1.29 0.84 0.045 
Gng11 1.28 2.1 0.027 
Dnaja2 1.27 2.39 0.032 
Becn1 1.26 2.11 0.049 
Tmed5 1.26 2.48 0.047 
Tmem147 1.26 0.95 0.027 
Trmt5 1.24 2.26 0.033 
Srsf5 1.23 2.25 0.02 
Gm16062 1.23 1.9 0.012 
Ebi3 1.22 0.89 0.044 
Mpeg1 1.21 1.7 0.046 
Rab33a 1.21 0.87 0.049 
Nol12 1.2 0.93 0.016 
Psmb9 1.2 0.89 0.012 
Cdca3 1.19 0.91 0.025 
Chm 1.19 2.61 0.044 
Frs2 1.19 1.77 0.05 
Vrk3 1.18 0.81 0.013 




Supplemental Table 1 (continued) 
Gene Symbol WT  KO  p-value 
Slc38a2 1.15 2.02 0.041 
Dbt 1.15 2.26 0.044 
Ptprcap 1.15 0.71 0.011 
Fas 1.15 2.4 0.039 
Ikzf5 1.15 2.31 0.03 
Igsf23 1.14 0.8 0.042 
Rnf149 1.13 1.97 0.014 
Copz2 1.13 0.83 0.047 
Cox8a 1.11 0.87 0.031 
Ipo8 1.11 1.51 0.042 
Krtcap2 1.11 0.85 0.035 
Hnrnpc 1.11 1.81 0.042 
Vps29 1.11 2.21 0.035 
Lat2 1.1 0.82 0.012 
Nxpe5 1.09 0.78 0.043 
Ddx21 1.09 1.53 0.047 
Dnttip1 1.08 0.84 0.032 
Ddx46 1.08 1.52 0.05 
Ddx3y 1.07 2.45 0.017 
Zfp326 1.06 1.98 0.039 
Hgsnat 1.06 1.24 0.049 
Nrbf2 1.05 2.2 0.004 
Dhrs7c 1.05 0.8 0.015 
Spry2 1.05 2.09 0.049 




Supplemental Table 1 (continued) 
Gene Symbol WT  KO  p-value 
Zpr1 1.03 0.82 0.045 
Nelfe 1.02 0.72 0.007 
Rac3 1.01 0.77 0.027 
Slc22a5 1 1.49 0.035 
Tsacc 1 1.68 0.048 
Sorbs1 0.99 1.87 0.039 
2900009J06Rik 0.99 2.21 0.016 
Tcea1 0.99 1.84 0.039 
Fam89b 0.98 0.69 0.032 
Copb2 0.96 1.72 0.038 
Sec23ip 0.96 1.53 0.042 
Cobll1 0.96 1.72 0.04 
Clec12a 0.95 1.35 0.018 
Cdkn1b 0.95 2.29 0.031 
Mmaa 0.94 1.34 0.045 
Calm1 0.94 1.68 0.029 
Sh3bp1 0.94 0.69 0.013 
Hnrnph2 0.92 1.72 0.022 
Mrpl55 0.92 1.08 0.04 
Ccl8 0.92 2.42 0.034 
Agpat2 0.91 0.69 0.044 
Ecd 0.91 1.09 0.049 
Fgf1 0.91 1.22 0.02 
Ndufaf6 0.91 1.55 0.038 




Supplemental Table 1 (continued) 
Gene Symbol WT  KO  p-value 
Hnrnpa3 0.89 1.62 0.022 
Otud1 0.89 2.04 0.04 
Habp2 0.89 0.72 0.038 
Decr2 0.88 1.3 0.034 
Napsa 0.88 0.69 0.044 
Fars2 0.88 0.77 0.035 
Metap1d 0.88 1.27 0.026 
Eva1b 0.87 0.72 0.042 
Sos2 0.87 1.39 0.049 
Med18 0.87 1.15 0.038 
Cenpt 0.87 0.63 0.002 
Atpaf2 0.87 0.71 0.044 
Agrn 0.86 1.05 0.028 
Relt 0.86 0.65 0.049 
Dld 0.86 1.96 0.036 
Adpgk 0.86 1.12 0.03 
Npl 0.86 1.13 0.032 
Slc39a7 0.85 0.66 0.006 
Cers4 0.84 1.03 0.047 
Cma1 0.84 1.13 0.044 
Fbxo33 0.83 1.32 0.018 
Eif5a 0.83 0.73 0.03 
Fam98b 0.82 1.53 0.047 
Tldc1 0.82 0.59 0.026 




Supplemental Table 1 (continued) 
Gene Symbol WT  KO  p-value 
Prpf4b 0.82 1.35 0.05 
Ggnbp2os 0.81 1.02 0.028 
Psma6 0.79 1.39 0.014 
Snrpa 0.78 0.6 0.003 
Ramp3 0.78 0.69 0.015 
Faf1 0.78 1.16 0.019 
AA467197 0.78 1.43 0.016 
Xpnpep1 0.77 0.68 0.032 
Ino80e 0.77 0.61 0.005 
Clybl 0.77 1.1 0.023 
Cd59a 0.76 0.99 0.046 
Nmnat3 0.76 1.07 0.034 
Mgmt 0.74 0.92 0.037 
Loxl1 0.74 0.59 0.036 
Rhoa 0.74 1.22 0.018 
Cfd 0.74 0.88 0.002 
Myl6b 0.74 0.46 0.035 
Tspyl1 0.74 1.45 0.023 
Hamp 0.73 1.04 0.048 
Spout1 0.72 0.97 0.042 
Tob2 0.72 1.31 0.043 
Rasa4 0.72 0.59 0.046 
Tbrg1 0.71 1.15 0.047 
Faap20 0.71 0.83 0.008 




Supplemental Table 1 (continued) 
Gene Symbol WT  KO  p-value 
Rpp25 0.7 0.92 0.026 
Dhdds 0.7 0.56 0.048 
Arap3 0.68 0.79 0.038 
Il18bp 0.68 1.08 0.034 
Stap2 0.68 0.9 0.032 
Colq 0.67 0.47 0.043 
Nploc4 0.65 0.57 0.02 
Lamc1 0.65 0.85 0.047 
Maf 0.65 1.12 0.003 
Hmga1b 0.64 0.47 0.029 
Anxa6 0.63 0.54 0.042 
Hgs 0.63 0.54 0.005 
Arhgap10 0.62 0.52 0.035 
Rtfdc1 0.62 0.52 0.017 
Arrb2 0.62 0.71 0.041 
Gpi1 0.61 0.51 0.012 
Stab1 0.59 0.69 0.028 
Dpp3 0.59 0.52 0.019 
Polg 0.59 0.71 0.03 
Xrcc1 0.59 0.64 0.041 
Tpi1 0.59 0.5 0.035 
Tmem208 0.57 0.75 0.003 
Gmppb 0.57 0.67 0.025 
Ctdnep1 0.56 0.51 0.042 




Supplemental Table 1 (continued) 
Gene Symbol WT  KO  p-value 
Coq8b 0.55 0.44 0.038 
Ifi30 0.54 0.67 0.026 
 Rhot2 0.54 0.43 0 
Gm5643 0.53 1.66 0.038 
Rps4l 0.52 0.84 0.017 
Gstt2 0.52 0.66 0.002 
Anapc2 0.51 0.4 0.029 
Chpf2 0.51 0.69 0.021 
Tbcc 0.51 0.64 0.011 
Hdac11 0.51 0.72 0.009 
Inf2 0.5 0.58 0.021 
Oas1a 0.49 0.71 0.033 
Jsrp1 0.47 0.68 0.034 
Coro1a 0.46 0.54 0.037 
Snrpb 0.46 0.36 0.016 
Map3k10 0.46 0.62 0.046 
Plcd3 0.45 0.6 0.042 
Clec2d 0.44 0.77 0.04 
Insl3 0.39 1.07 0.015 








Supplemental Table 2: Differentially expressed mRNAs in cardiac tissue between WT 
and KO.  
 
Supplemental Table 2. 
Note: Values represent normalized expression to the geometric mean of four 
genes (Vcp, Rps6, Rpl38 and Gapdh). 
Gene Symbol WT  KO  p-value 
Ptgds 371.5 248.8 0.026 
Rpl3l 181.8 52 0.006 
Ninj1 123.7 92.6 0.038 
Eif4a2 103.6 50.1 0.014 
Selenom 99.1 69.6 0.046 
Eif4g2 81.4 47.1 0.046 
Ppp1cb 65.1 31.1 0.012 
Calm1 60 35.4 0.01 
Hnrnpk 56.2 33.2 0.036 
Srsf5 49.7 26.2 0.024 
Qk 48.4 26.9 0.036 
Zmat5 39.1 29.1 0.017 
Tspyl1 39 19.8 0.018 
Rbm42 36.9 28.2 0.046 
Mgmt 34.7 24.5 0.034 
Pdia3 29.5 15 0.017 
Ssb 28.2 15.1 0.031 
Chmp2b 27 11.2 0.036 
Nampt 26.4 13.5 0.041 
C1qtnf4 26.3 16.9 0.046 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Tmem219 23.3 17.1 0.042 
Snapc5 23.3 10 0.024 
2310009B15Rik 23 10.8 0.048 
Ddx24 22.5 19.5 0.008 
Tob1 22.2 10.9 0.041 
Hnrnph2 22.2 13 0.013 
Tnfaip8 21.9 12.6 0.027 
Pex2 21.8 13.9 0.034 
Osbpl1a 21.6 14.1 0.03 
Osgepl1 20.1 10.4 0.027 
Cast 19.9 14.2 0.042 
Polr1c 19.8 15.8 0.008 
Dusp23 19.7 15.1 0.05 
Mef2a 19.6 12.1 0.023 
Mrm2 19.5 12 0.027 
Copb2 19.5 10.7 0.02 
Hnrnpa3 18.8 11.1 0.021 
Ddx3y 18.6 8.6 0.007 
Zfp358 18.6 23.5 0.045 
Naprt 18.4 12.5 0.009 
Myot 18.3 10.8 0.006 
Gm5643 18.2 7.3 0.014 
Tbrg1 18.1 12.1 0.019 
Dnm1l 18.1 11.4 0.044 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Yae1d1 17.6 9.6 0.041 
Pja2 17.6 9.7 0.04 
Matr3 17.6 8.4 0.04 
Slc17a7 17.5 13.9 0.04 
Rab5a 17.1 8.3 0.016 
Paip1 16.5 9.7 0.017 
Rab9 16.3 6.7 0.039 
Lrtm1 16.3 12.9 0.024 
Dbt 16.2 8 0.011 
Cdkn1b 15.6 7 0.034 
Nabp1 15.5 8.7 0.026 
Fgfr1op2 15.3 8.2 0.034 
Ino80b 15.2 11.1 0.028 
Nudt14 14.7 9.5 0.042 
Aar2 14.5 10.8 0.048 
Cobll1 14.4 7.9 0.025 
Hdac2 14.3 7.3 0.043 
Tfrc 14.3 7.1 0.021 
Mreg 13.5 6.7 0.029 
Fhl3 13.2 9.7 0.024 
Aasdhppt 13.1 8.4 0.037 
Ppox 13.1 7.3 0.049 
Slc38a2 13 8.1 0.022 
Med11 12.8 8 0.044 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Eif2s3y 11.8 6 0.015 
4921524J17Rik 11.6 6.1 0.03 
Atg10 11.5 5.3 0.025 
Tra2b 11.4 7.5 0.031 
Decr2 11.3 6.5 0.04 
Commd8 11.2 7.4 0.029 
E130309D02Rik 11.1 7.7 0.013 
Pcnp 10.9 7.4 0.039 
Serf1 10.7 5.4 0.027 
Mitf 10.7 6.7 0.034 
Hdac11 10.6 6.4 0.038 
Snap23 10.6 6.2 0.041 
Lsm8 10.6 5.3 0.038 
Ola1 10.2 6 0.036 
Abhd14b 10.2 7 0.042 
Crk 10.2 7 0.043 
Otud1 10.1 5.3 0.032 
Pdcd10 10 4.4 0.017 
Nrbf2 10 4.2 0.014 
Tomm70a 9.8 5.9 0.044 
Sms 9.5 5.8 0.045 
Nudt21 9.4 6.2 0.021 
Uph 9.2 6.1 0.011 
Pdss1 9 5.6 0.045 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Asf1a 8.9 3.6 0.009 
Mgea5 8.7 5.4 0.049 
Klhl24 8.5 4.4 0.021 
Btg3 8.4 5.6 0.049 
Trmt5 8.3 4.7 0.05 
Zfp639 8.2 5.5 0.042 
Prrx1 8.2 5.6 0.046 
Lyrm7 8.1 3.7 0.008 
Dhx15 8 4.7 0.022 
Lpgat1 8 4.8 0.032 
Tmem37 7.9 5.7 0.013 
Uso1 7.8 4.3 0.032 
Reps1 7.8 6.1 0.04 
Gal3st3 7.7 4.5 0.026 
Ccdc58 7.5 4.5 0.042 
Maf 7.5 4.9 0.028 
Dcun1d1 7.4 4.6 0.03 
Tmx4 7.4 4 0.009 
Phkb 7.3 3.5 0.015 
Fam45a 7.2 4.5 0.03 
Faap100 7.2 6.1 0.046 
Selenoo 7.2 5.7 0.041 
Ube3a 7.1 5.3 0.04 
Ip6k3 7 4.8 0.015 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Ado 6.9 4.5 0.025 
Shoc2 6.9 4.8 0.033 
Lactb2 6.9 3.4 0.047 
Thumpd3 6.8 4.4 0.011 
Zfpm1 6.8 6 0.01 
Fsd1l 6.8 4.6 0.034 
Nr3c1 6.7 3.3 0.02 
Tmem38b 6.6 3.2 0.031 
Map2k3os 6.6 3.2 0.022 
Hspb11 6.5 4.2 0.036 
BC028528 6.5 4.3 0.046 
Lyar 6.4 3.9 0.049 
Mob3a 6.4 4.6 0.021 
Ikzf5 6.3 3.2 0.04 
Rbfox1 6.2 3.5 0.024 
Atxn7l1 6.2 3.6 0.016 
Slc33a1 6.2 4 0.046 
Polrmt 6.1 4.6 0.036 
Ptprn 6 4.3 0.038 
Pex13 6 3.1 0.033 
Smarca5 6 3.5 0.041 
Mtpap 5.7 3.7 0.019 
Lactb 5.7 3.5 0.029 
Rpl32l 5.7 4.1 0.011 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Ppp2r5e 5.6 3.6 0.048 
Ddx41 5.6 4.2 0.029 
Tdp2 5.6 3.2 0.012 
Tfb1m 5.5 2.9 0.025 
Cpne1 5.5 3.3 0.039 
Ccdc43 5.4 3.7 0.01 
Lrrc42 5.4 3.1 0.029 
Mboat2 5.4 2.6 0.021 
Rps6kb1 5.2 3.5 0.045 
Usp15 5.2 3.6 0.033 
Prpf4b 5.2 3.1 0.04 
2610507I01Rik 5.2 1.7 0.024 
Fgfr1op 5.2 3.6 0.038 
Zfp326 5.2 2.9 0.024 
Mtdh 5 3.1 0.046 
Alg9 5 3.6 0.045 
Kcnn2 5 3.4 0.048 
C8g 5 3.4 0.04 
Evi2a 5 3.3 0.026 
Yes1 4.9 3.2 0.047 
Nmrk2 4.9 3 0.033 
Arrdc3 4.9 2.8 0.04 
Herc4 4.8 3.3 0.019 
Gm17066 4.8 3.2 0.046 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Prg4 4.8 3.1 0.038 
Nr2f2 4.6 3.1 0.045 
BC003331 4.6 2.9 0.035 
Mdfic 4.6 2.6 0.045 
Wbp4 4.6 3 0.047 
Zfp715 4.5 2.5 0.022 
Lin52 4.5 2.7 0.025 
Efemp1 4.4 2.2 0.029 
Lingo3 4.4 3.7 0.046 
Actr6 4.4 2.5 0.042 
Far1 4.3 2.9 0.02 
Ppp1r1a 4.3 2.4 0.018 
Rnf149 4.2 2.3 0.041 
Gca 4.2 2.1 0.032 
Trmo 4.1 3.2 0.036 
Dip2c 4 2.4 0.011 
Mindy2 4 2.6 0.046 
Esf1 3.8 2.3 0.021 
Fam133b 3.8 2.2 0.017 
Dnaaf3 3.8 3 0.032 
Ufl1 3.8 2.5 0.034 
Cd53 3.7 2.3 0.04 
Intu 3.6 1.9 0.01 
Taf2 3.6 2.3 0.022 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Oxsm 3.6 2.2 0.038 
Smad1 3.6 2.4 0.01 
5730455P16Rik 3.5 2.1 0.014 
4930429F24Rik 3.5 2.2 0.05 
Pnisr 3.5 2.3 0.007 
Hps6 3.5 2.4 0.021 
E130311K13Rik 3.5 1.5 0.006 
Cep19 3.4 2 0.011 
Acbd3 3.4 1.9 0.036 
Secisbp2l 3.4 2.2 0.048 
Rnf113a2 3.4 1.8 0.017 
Pkn2 3.4 2.1 0.032 
Gnai3 3.2 1.9 0.038 
Armcx5 3.2 2 0.022 
Chm 3.2 1.9 0.018 
Zfp148 3.2 2 0.045 
Nup54 3.1 2.1 0.029 
Wdr75 3.1 1.9 0.049 
Zfp317 3.1 2 0.022 
Stk17b 3.1 2 0.036 
Ssfa2 3 2 0.036 
Ubxn2a 3 2 0.039 
Ranbp6 2.9 1.7 0.01 
Klhl2 2.9 1.9 0.025 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
Wif1 2.7 1.2 0.011 
Ltn1 2.7 1.8 0.022 
Gm6416 2.6 1.5 0.03 
Clec11a 2.5 1.8 0.041 
Qser1 2.5 1.7 0.024 
Efnb2 2.5 1.8 0.014 
Iqcb1 2.5 1.5 0.02 
Ddx10 2.5 1.6 0.026 
Thap6 2.4 1.4 0.025 
Gmds 2.4 1.5 0.036 
Tlr2 2.4 1.8 0.006 
Fam76b 2.4 1.6 0.044 
Morc3 2.3 1.7 0.039 
Ep300 2.3 1.7 0.029 
Nupl1 2.3 1.4 0.031 
Rspry1 2.3 1.6 0.048 
Map10 2.3 1.3 0.016 
Cyp2j6 2.3 1.5 0.041 
Ccdc68 2.2 1.6 0.014 
Donson 2.2 1.2 0.012 
Zrsr1 2.1 1.4 0.035 
Togaram1 2.1 1.5 0.034 
Mpeg1 2.1 1.8 0.02 
Pggt1b 2.1 1.4 0.049 




Supplemental Table 2 (continued) 
Gene Symbol WT  KO  p-value 
2610002M06Rik 2.1 1.3 0.05 
Gipc2 2 1.4 0.032 
Pid1 2 1.4 0.048 
Zfp960 2 1.6 0.026 
Ap5m1 2 1.4 0.048 
6820431F20Rik 2 1.3 0.027 
Btaf1 1.9 1.3 0.033 
Pibf1 1.9 1.3 0.048 
Man2c1os 1.8 1.1 0.024 
Gm15441 1.8 1.2 0.039 
Gm266 1.8 1.5 0.046 
Wdpcp 1.7 1.2 0.049 
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